Plasmin	B-protein
-induced	O
expression	O
of	O
cytokines	B-protein
and	O
tissue	B-protein
factor	I-protein
in	O
human	B-cell_type
monocytes	I-cell_type
involves	O
AP-1	B-protein
and	O
IKKbeta	B-protein
-mediated	O
NF-kappaB	O
activation	O
.	O

It	O
was	O
previously	O
shown	O
that	O
plasmin	B-protein
activates	O
human	B-cell_type
peripheral	I-cell_type
monocytes	I-cell_type
in	O
terms	O
of	O
lipid	O
mediator	O
release	O
and	O
chemotactic	O
migration	O
.	O

Here	O
it	O
is	O
demonstrated	O
that	O
plasmin	B-protein
induces	O
proinflammatory	B-protein
cytokine	I-protein
release	O
and	O
tissue	B-protein
factor	I-protein
(	O
TF	B-protein
)	O
expression	O
by	O
monocytes	B-cell_type
.	O

Plasmin	B-protein
0.043	O
to	O
1.43	O
CTA	O
U/mL	O
,	O
but	O
not	O
active	B-protein
site-blocked	I-protein
plasmin	I-protein
,	O
triggered	O
concentration-dependent	O
expression	O
of	O
mRNA	O
for	O
interleukin-1alpha	B-protein
(	O
IL-1alpha	B-protein
)	O
,	O
IL-1beta	B-protein
,	O
tumor	B-protein
necrosis	I-protein
factor-alpha	I-protein
(	O
TNF-alpha	B-protein
)	O
,	O
and	O
TF	B-protein
with	O
maximum	O
responses	O
after	O
4	O
hours	O
.	O

Plasmin	B-protein
-mediated	O
mRNA	O
expression	O
was	O
inhibited	O
in	O
a	O
concentration-dependent	O
manner	O
by	O
the	O
lysine	O
analogue	O
trans-4-	O
(	O
aminomethyl	O
)	O
cyclohexane-1-carboxylic	O
acid	O
(	O
t-AMCA	O
)	O
.	O

Increases	O
in	O
mRNA	O
levels	O
were	O
followed	O
by	O
concentration-	O
and	O
time-dependent	O
release	O
of	O
IL-1alpha	B-protein
,	O
IL-1beta	B-protein
and	O
TNF-alpha	B-protein
and	O
by	O
TF	B-protein
expression	O
on	O
monocyte	O
surfaces	O
.	O

Neither	O
cytokines	B-protein
nor	O
TF	B-protein
could	O
be	O
detected	O
when	O
monocytes	B-cell_type
were	O
preincubated	O
with	O
actinomycin	O
D	O
or	O
cycloheximide	O
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
indicated	O
plasmin	B-protein
-induced	O
activation	O
of	O
NF-kappaB	B-protein
;	O
DNA-binding	B-protein
complexes	I-protein
were	O
composed	O
of	O
p50	B-protein
,	O
p65	B-protein
,	O
and	O
c-Rel	B-protein
,	O
as	O
shown	O
by	O
supershift	O
experiments	O
.	O

Nuclear	O
translocation	O
of	O
NF-kappaB/Rel	B-protein
proteins	I-protein
coincided	O
with	O
IkappaBalpha	O
degradation	O
.	O

At	O
variance	O
with	O
endotoxic	O
lipopolysaccharide	O
,	O
plasmin	B-protein
elicited	O
the	O
rapid	O
degradation	O
of	O
another	O
cytoplasmic	B-protein
NF-kappaB	I-protein
inhibitor	I-protein
,	I-protein
p105	I-protein
.	O

Proteolysis	O
of	O
NF-kappaB	O
inhibitors	O
was	O
apparently	O
due	O
to	O
transient	O
activation	O
of	O
IkappaB	B-protein
kinase	I-protein
(	I-protein
IKK	I-protein
)	I-protein
beta	I-protein
that	O
reached	O
maximum	O
activity	O
at	O
1	O
hour	O
after	O
plasmin	B-protein
stimulation	O
.	O

In	O
addition	O
,	O
AP-1	O
binding	O
was	O
increased	O
in	O
plasmin	B-protein
-treated	O
monocytes	B-cell_type
,	O
with	O
most	O
complexes	O
composed	O
of	O
JunD	B-protein
,	O
c-Fos	B-protein
,	O
and	O
FosB	B-protein
.	O

These	O
findings	O
further	O
substantiate	O
the	O
role	O
of	O
plasmin	B-protein
as	O
a	O
proinflammatory	O
activator	O
of	O
human	B-cell_type
monocytes	I-cell_type
and	O
reveal	O
an	O
important	O
new	O
link	O
between	O
the	O
plasminogen-plasmin	O
system	O
and	O
inflammation	O
.	O

(	O
Blood.	O
2001	O
;	O
97	O
:	O
3941-3950	O
)	O

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

PHAGOCYTES	NULL
Plasmin-induced	NULL
expression	NULL
of	NULL
cytokines	NULL
and	NULL
tissue	NULL
factor	NULL
in	NULL
human	NULL
monocytes	NULL
involves	NULL
AP-1	NULL
and	NULL
IKKB-mediated	NULL
NF-KB	NULL
activation	NULL
Tatiana	NULL
Syrovets	NULL
,	NULL
Marina	NULL
Jendrach	NULL
,	NULL
Angela	NULL
Rohwedder	NULL
,	NULL
Almut	NULL
Schule	NULL
,	NULL
and	NULL
Thomas	NULL
Simmet	NULL
It	NULL
was	NULL
previously	NULL
shown	NULL
that	NULL
plasmin	NULL
activates	NULL
human	NULL
peripheral	NULL
monocytes	NULL
in	NULL
terms	NULL
of	NULL
lipid	NULL
mediator	NULL
release	NULL
and	NULL
chemotactic	NULL
migration	NULL
.	NULL

Here	NULL
it	NULL
is	NULL
demonstrated	NULL
that	NULL
plasmin	NULL
induces	NULL
proinflammatory	NULL
cytokine	NULL
release	NULL
and	NULL
tissue	NULL
factor	NULL
(	NULL
TF	NULL
)	NULL
expression	NULL
by	NULL
monocytes	NULL
.	NULL

Plasmin	NULL
0.043	NULL
to	NULL
1.43	NULL
CTA	NULL
U/mL	NULL
,	NULL
but	NULL
not	NULL
active	NULL
site-blocked	NULL
plasmin	NULL
,	NULL
triggered	NULL
concentration-dependent	NULL
expression	NULL
of	NULL
mRNA	NULL
for	NULL
interleukin-1	NULL
«	NULL
(	NULL
IL-1	NULL
)	NULL
,	NULL
IL-1	NULL
B	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
(	NULL
TNF-	NULL
«	NULL
)	NULL
,	NULL
and	NULL
TF	NULL
with	NULL
maximum	NULL
responses	NULL
after	NULL
4	NULL
hours	NULL
.	NULL

Plasmin-mediated	NULL
mRNA	NULL
expression	NULL
was	NULL
inhibited	NULL
in	NULL
a	NULL
concentration-dependent	NULL
manner	NULL
by	NULL
the	NULL
lysine	NULL
analogue	NULL
franms-4-	NULL
(	NULL
amino-	NULL
methyl	NULL
)	NULL
cyclohexane-1-carboxylic	NULL
acid	NULL
(	NULL
t-AMCA	NULL
)	NULL
.	NULL

Increases	NULL
in	NULL
mRNA	NULL
levels	NULL
were	NULL
followed	NULL
by	NULL
concentration-	NULL
and	NULL
time-dependent	NULL
release	NULL
of	NULL
IL-1	NULL
«	NULL
,	NULL
IL-1B	NULL
and	NULL
TNF-a	NULL
and	NULL
by	NULL
TF	NULL
expression	NULL
on	NULL
monocyte	NULL
surfaces	NULL
.	NULL

Neither	NULL
cytokines	NULL
nor	NULL
TF	NULL
could	NULL
be	NULL
detected	NULL
when	NULL
monocytes	NULL
were	NULL
preincubated	NULL
with	NULL
actinomycin	NULL
D	NULL
or	NULL
cyclo-heximide	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
indicated	NULL
plasmin-induced	NULL
activation	NULL
of	NULL
NF-kB	NULL
;	NULL
DNA-binding	NULL
complexes	NULL
were	NULL
composed	NULL
of	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
c-Rel	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
supershift	NULL
experiments	NULL
.	NULL

Nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
coincided	NULL
with	NULL
IkBa	NULL
degradation	NULL
.	NULL

At	NULL
variance	NULL
with	NULL
endotoxic	NULL
lipopolysaccharide	NULL
,	NULL
plasmin	NULL
elicited	NULL
the	NULL
rapid	NULL
degradation	NULL
of	NULL
another	NULL
cytoplasmic	NULL
NF-kB	NULL
inhibitor	NULL
,	NULL
p105	NULL
.	NULL

Proteolysis	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
inhibitors	NULL
was	NULL
apparently	NULL
due	NULL
to	NULL
transient	NULL
activation	NULL
of	NULL
IB	NULL
kinase	NULL
(	NULL
IKK	NULL
)	NULL
B	NULL
that	NULL
reached	NULL
maximum	NULL
activity	NULL
at	NULL
1	NULL
hour	NULL
after	NULL
plasmin	NULL
stimulation	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
AP-1	NULL
binding	NULL
was	NULL
increased	NULL
in	NULL
plasmin-treated	NULL
monocytes	NULL
,	NULL
with	NULL
most	NULL
complexes	NULL
composed	NULL
of	NULL
JunD	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
FosB	NULL
.	NULL

These	NULL
findings	NULL
further	NULL
substantiate	NULL
the	NULL
role	NULL
of	NULL
plasmin	NULL
as	NULL
a	NULL
proinflammatory	NULL
activator	NULL
of	NULL
human	NULL
monocytes	NULL
and	NULL
reveal	NULL
an	NULL
important	NULL
new	NULL
link	NULL
between	NULL
the	NULL
plasminogen-plasmin	NULL
system	NULL
and	NULL
inflammation	NULL
.	NULL

(	NULL
Blood	NULL
.	NULL

2001	NULL
;	NULL
97:3941-3950	NULL
)	NULL
©2001	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
Introduction	NULL
Most	NULL
blood	NULL
cells	NULL
,	NULL
including	NULL
monocytes	NULL
,	NULL
bind	NULL
plasmin	NULL
and	NULL
plasminogen	NULL
through	NULL
low-affinity	NULL
binding	NULL
sites	NULL
,	NULL
a	NULL
fact	NULL
that	NULL
has	NULL
usually	NULL
been	NULL
regarded	NULL
in	NULL
terms	NULL
of	NULL
fibrinolytic	NULL
activity	NULL
.	NULL
``	NULL

However	NULL
,	NULL
several	NULL
stud-ies*	NULL
``	NULL
suggest	NULL
that	NULL
the	NULL
serine	NULL
protease	NULL
plasmin	NULL
might	NULL
have	NULL
physiological	NULL
functions	NULL
beyond	NULL
fibrinolysis	NULL
.	NULL

Thus	NULL
,	NULL
plasmin	NULL
induces	NULL
neutrophil	NULL
aggregation	NULL
,	NULL
platelet	NULL
degranulation	NULL
,	NULL
and	NULL
arachidonate	NULL
release	NULL
from	NULL
endothelial	NULL
cells	NULL
,	NULL
implying	NULL
activity	NULL
as	NULL
a	NULL
proinflammatory	NULL
Moreover	NULL
,	NULL
plasmin	NULL
was	NULL
found	NULL
to	NULL
be	NULL
a	NULL
potent	NULL
and	NULL
selective	NULL
stimulus	NULL
for	NULL
human	NULL
peripheral	NULL
monocytes	NULL
.	NULL
``	NULL

In	NULL
monocytes	NULL
,	NULL
plasmin	NULL
triggered	NULL
the	NULL
release	NULL
of	NULL
lipid	NULL
mediators	NULL
,	NULL
such	NULL
as	NULL
the	NULL
chemotactic	NULL
leukotriene	NULL
B4	NULL
,	NULL
and	NULL
a	NULL
chemotactic	NULL
response	NULL
equipotent	NULL
to	NULL
that	NULL
of	NULL
N-formyl-methionine-leucine-phenylalanine	NULL
.	NULL

**	NULL
Studies	NULL
with	NULL
transgenic	NULL
mice	NULL
revealed	NULL
that	NULL
plasmin	NULL
is	NULL
important	NULL
for	NULL
monocyte	NULL
recruitment	NULL
to	NULL
sites	NULL
of	NULL
inflammation	NULL
and	NULL
for	NULL
the	NULL
development	NULL
of	NULL
atherosclerotic	NULL
lesions	NULL
.	NULL
``	NULL

''	NULL
Additional	NULL
support	NULL
for	NULL
an	NULL
extended	NULL
pathophysiological	NULL
function	NULL
of	NULL
plasmin	NULL
in	NULL
vivo	NULL
comes	NULL
from	NULL
clinical	NULL
studies	NULL
showing	NULL
elevated	NULL
levels	NULL
of	NULL
plasmin	NULL
in	NULL
synovial	NULL
fluid	NULL
from	NULL
arthritic	NULL
joints	NULL
and	NULL
an	NULL
increased	NULL
expression	NULL
of	NULL
fibrinolytic	NULL
genes	NULL
in	NULL
atherosclerotic	NULL
lesions	NULL
.	NULL

``	NULL
!	NULL

Nuclear	NULL
factor-kB	NULL
(	NULL
NF-KB	NULL
)	NULL
is	NULL
a	NULL
ubiquitous	NULL
transcription	NULL
factor	NULL
that	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
numerous	NULL
genes	NULL
,	NULL
including	NULL
early-response	NULL
genes	NULL
encoding	NULL
cytokines	NULL
,	NULL
adhesion	NULL
molecules	NULL
,	NULL
and	NULL
tissue	NULL
factor	NULL
.	NULL
'	NULL

''	NULL
4	NULL
Disorders	NULL
in	NULL
NF-kB	NULL
activation	NULL
have	NULL
been	NULL
linked	NULL
to	NULL
inflammatory	NULL
reactions	NULL
associated	NULL
with	NULL
arthritis	NULL
,	NULL
atherosclerosis	NULL
,	NULL
septic	NULL
shock	NULL
,	NULL
and	NULL
various	NULL
other	NULL
diseases	NULL
.	NULL

'*	NULL
``	NULL
4	NULL
In	NULL
resting	NULL
cells	NULL
,	NULL
the	NULL
NE-kB/Rel	NULL
nuclear	NULL
factors	NULL
reside	NULL
in	NULL
the	NULL
cytoplasm	NULL
bound	NULL
to	NULL
inhibitory	NULL
proteins	NULL
.	NULL
``	NULL

Five	NULL
members	NULL
of	NULL
the	NULL
NF-KB	NULL
family	NULL
have	NULL
been	NULL
identified	NULL
.	NULL

The	NULL
most	NULL
abundant	NULL
form	NULL
of	NULL
NF-KB	NULL
is	NULL
a	NULL
heterodimer	NULL
composed	NULL
of	NULL
a	NULL
p65	NULL
subunit	NULL
and	NULL
a	NULL
p50	NULL
or	NULL
p52	NULL
subunit	NULL
.	NULL

Other	NULL
complexes	NULL
,	NULL
such	NULL
as	NULL
p65/c-Rel	NULL
,	NULL
have	NULL
also	NULL
been	NULL
detected	NULL
.	NULL

'*	NULL
!	NULL

*	NULL
Although	NULL
NF-KB	NULL
is	NULL
considered	NULL
a	NULL
genetic	NULL
switch	NULL
for	NULL
early-response	NULL
genes	NULL
,	NULL
the	NULL
synergistic	NULL
interaction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
optimal	NULL
induction	NULL
of	NULL
distinct	NULL
gene	NULL
expression	NULL
.	NULL
'	NULL

''	NULL
~	NULL
'	NULL
``	NULL
Cooperative	NULL
and	NULL
coordinate	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
kB	NULL
and	NULL
AP-1	NULL
transcription	NULL
factors	NULL
enhances	NULL
the	NULL
activity	NULL
of	NULL
cytokine	NULL
and	NULL
TF	NULL
gene	NULL
promoters	NULL
.	NULL

``	NULL
``	NULL
~	NULL
'	NULL
``	NULL
Transcription	NULL
factor	NULL
AP-1	NULL
is	NULL
composed	NULL
of	NULL
Jun	NULL
homodimers	NULL
or	NULL
Jun/Fos	NULL
heterodimers	NULL
.	NULL

AP-1	NULL
is	NULL
activated	NULL
by	NULL
a	NULL
wide	NULL
array	NULL
of	NULL
stimuli	NULL
and	NULL
is	NULL
implicated	NULL
in	NULL
such	NULL
different	NULL
processes	NULL
as	NULL
cell	NULL
cycle	NULL
progression	NULL
,	NULL
cell	NULL
cycle	NULL
arrest	NULL
,	NULL
and	NULL
apoptosis	NULL
!	NULL
``	NULL

and	NULL
in	NULL
leukocyte	NULL
activation	NULL
and	NULL
differentiation	NULL
.	NULL
``	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
plasmin-induced	NULL
activation	NULL
of	NULL
human	NULL
peripheral	NULL
monocytes	NULL
in	NULL
terms	NULL
of	NULL
proinflammatory	NULL
gene	NULL
expression	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
in	NULL
human	NULL
peripheral	NULL
monocytes	NULL
,	NULL
plasmin	NULL
stimulates	NULL
proinflammatory	NULL
cytokines	NULL
and	NULL
TF	NULL
expression	NULL
associated	NULL
with	NULL
proinflammatory	NULL
activation	NULL
of	NULL
macrophages	NULL
,	NULL
``	NULL
``	NULL
indicating	NULL
a	NULL
new	NULL
link	NULL
between	NULL
the	NULL
plasminogen/plasmin	NULL
system	NULL
and	NULL
inflammation	NULL
.	NULL

We	NULL
further	NULL
show	NULL
that	NULL
plasmin-induced	NULL
signal	NULL
transduction	NULL
entails	NULL
the	NULL
activation	NULL
of	NULL
transcription	NULL
factors	NULL
and	NULL
AP-1	NULL
.	NULL

From	NULL
the	NULL
Department	NULL
of	NULL
Pharmacology	NULL
of	NULL
Natural	NULL
Products	NULL
and	NULL
Clinical	NULL
Pharmacology	NULL
,	NULL
University	NULL
of	NULL
Um	NULL
,	NULL
Germany	NULL
;	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Virology	NULL
,	NULL
University	NULL
of	NULL
Bochum	NULL
,	NULL
Germany	NULL
.	NULL

Submitted	NULL
August	NULL
1	NULL
,	NULL
2000	NULL
;	NULL
accepted	NULL
February	NULL
20	NULL
,	NULL
2001	NULL
.	NULL

Supported	NULL
by	NULL
the	NULL
Deutsche	NULL
Forschungsgemeinschaft	NULL
SFB	NULL
451	NULL
.	NULL

Reprints	NULL
:	NULL
Thomas	NULL
Simmet	NULL
,	NULL
Dept	NULL
of	NULL
Pharmacology	NULL
of	NULL
Natural	NULL
Products	NULL
and	NULL
BLOOD	NULL
,	NULL
15	NULL
JUNE	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
12	NULL
Clinical	NULL
Pharmacology	NULL
,	NULL
University	NULL
of	NULL
Ulm	NULL
,	NULL
Helmholtzstrasse	NULL
20	NULL
,	NULL
D-89081	NULL
UIm	NULL
,	NULL
Germany	NULL
;	NULL
e-mail	NULL
:	NULL
thomas.simmet	NULL
@	NULL
medizin.uni-ulm.de	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

Therefore	NULL
,	NULL
and	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
,	NULL
this	NULL
article	NULL
is	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
.	NULL

©2001	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
3941	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3942	NULL
-	NULL
SYROVETS	NULL
etal	NULL
Materials	NULL
and	NULL
methods	NULL
Materials	NULL
Purified	NULL
human	NULL
plasmin	NULL
(	NULL
lots	NULL
354915	NULL
and	NULL
352817	NULL
;	NULL
specific	NULL
activity	NULL
,	NULL
14.83	NULL
CTA	NULL
U/mg	NULL
)	NULL
was	NULL
from	NULL
Fluka	NULL
(	NULL
Deisenhofen	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Antibodies	NULL
against	NULL
nuclear	NULL
factors	NULL
,	NULL
IxBa	NULL
and	NULL
IBB	NULL
,	NULL
IKKe	NULL
and	NULL
IKK	NULL
$	NULL
B	NULL
,	NULL
and	NULL
tagged	NULL
IxBa	NULL
fusion	NULL
protein	NULL
were	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Double-stranded	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
AP-2	NULL
,	NULL
and	NULL
SP-1	NULL
binding	NULL
sites	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
were	NULL
purchased	NULL
from	NULL
Promega	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

Anti-CD41	NULL
and	NULL
anti-CD14	NULL
monoclonal	NULL
antibodies	NULL
were	NULL
obtained	NULL
from	NULL
Immunotech	NULL
(	NULL
Marseilles	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Mouse	NULL
monoclonal	NULL
antibodies	NULL
against	NULL
human	NULL
TF	NULL
and	NULL
control	NULL
MOPC21	NULL
mouse	NULL
IgG	NULL
;	NULL
were	NULL
from	NULL
American	NULL
Diagnostica	NULL
(	NULL
Greenwich	NULL
,	NULL
CT	NULL
)	NULL
and	NULL
Sigma	NULL
(	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Lysine-free	NULL
RPMI	NULL
1640	NULL
,	NULL
the	NULL
Limulus	NULL
amebocyte	NULL
lysate	NULL
assay	NULL
cycloheximide	NULL
,	NULL
frans-4-	NULL
(	NULL
aminomethyl	NULL
)	NULL
cyclohexane-l-carboxylic	NULL
acid	NULL
(	NULL
t-AMCA	NULL
)	NULL
,	NULL
and	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
;	NULL
Escherichia	NULL
coli	NULL
serotype	NULL
055	NULL
:	NULL
B5	NULL
)	NULL
were	NULL
also	NULL
from	NULL
Sigma	NULL
.	NULL

Actinomycin	NULL
D	NULL
and	NULL
D-valyl-L-phenylalanyl-L-lysine	NULL
chloromethyl	NULL
ketone	NULL
were	NULL
from	NULL
Calbiochem	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Percoll	NULL
was	NULL
from	NULL
Pharmacia	NULL
Biotech	NULL
(	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

The	NULL
plasmin	NULL
substrate	NULL
S-2251	NULL
(	NULL
H-D-valyl-leucyl-L-lysine-P-nitroanilide	NULL
dihydrochlo-ride	NULL
)	NULL
was	NULL
supplied	NULL
by	NULL
Chromogenix	NULL
(	NULL
Mélndal	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

Oligo	NULL
(	NULL
dT	NULL
)	NULL
s	NULL
magnetic	NULL
beads	NULL
were	NULL
from	NULL
Dynal	NULL
(	NULL
Oslo	NULL
,	NULL
Norway	NULL
)	NULL
.	NULL

Other	NULL
chemicals	NULL
were	NULL
of	NULL
analytical	NULL
grade	NULL
.	NULL

Monocyte	NULL
preparation	NULL
and	NULL
incubation	NULL
Peripheral	NULL
monocytes	NULL
were	NULL
isolated	NULL
by	NULL
Percoll	NULL
gradient	NULL
centrifugation	NULL
.	NULL

**	NULL
Preparations	NULL
with	NULL
94	NULL
%	NULL
or	NULL
more	NULL
CD14	NULL
cells	NULL
were	NULL
used	NULL
.	NULL

Contaminating	NULL
cells	NULL
were	NULL
lymphocytes	NULL
(	NULL
2	NULL
%	NULL
-6	NULL
%	NULL
)	NULL
.	NULL

Flow	NULL
cytometry	NULL
of	NULL
cells	NULL
stained	NULL
additionally	NULL
with	NULL
anti-CD41	NULL
antibodies	NULL
did	NULL
not	NULL
reveal	NULL
any	NULL
platelets	NULL
associated	NULL
with	NULL
monocytes	NULL
.	NULL

Monocytes	NULL
were	NULL
generally	NULL
incubated	NULL
in	NULL
lysine-free	NULL
RPMI	NULL
1640	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
LPS	NULL
(	NULL
1	NULL
g/mL	NULL
)	NULL
,	NULL
a	NULL
concentration	NULL
that	NULL
was	NULL
found	NULL
to	NULL
yield	NULL
maximum	NULL
responses	NULL
in	NULL
terms	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
«	NULL
(	NULL
TNF-	NULL
«	NULL
)	NULL
and	NULL
TF	NULL
biosynthesis	NULL
,	NULL
or	NULL
LPS-free	NULL
human	NULL
plasmin	NULL
(	NULL
0.043-1.43	NULL
CTA	NULL
U/mL	NULL
)	NULL
.	NULL

All	NULL
plasmin	NULL
batches	NULL
were	NULL
regularly	NULL
checked	NULL
for	NULL
LPS	NULL
contamination	NULL
with	NULL
the	NULL
Limulus	NULL
amebocyte	NULL
lysate	NULL
assay	NULL
.	NULL

Occasionally	NULL
,	NULL
plasmin	NULL
was	NULL
added	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
lysine	NULL
analogue	NULL
t-	NULL
AMCA	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
monocytes	NULL
were	NULL
treated	NULL
for	NULL
4	NULL
hours	NULL
with	NULL
active	NULL
site-blocked	NULL
plasmin	NULL
,	NULL
equivalent	NULL
to	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
native	NULL
plasmin	NULL
.	NULL

D-Val-Phe-Lys	NULL
chloromethyl	NULL
ketone	NULL
(	NULL
VPLCK	NULL
)	NULL
was	NULL
used	NULL
to	NULL
block	NULL
the	NULL
catalytic	NULL
center	NULL
of	NULL
plasmin	NULL
.	NULL
``	NULL

Active	NULL
site-blocked	NULL
plasmin	NULL
had	NULL
no	NULL
detectable	NULL
residual	NULL
plasmin	NULL
activity	NULL
,	NULL
as	NULL
tested	NULL
with	NULL
S-2251	NULL
as	NULL
a	NULL
substrate	NULL
.	NULL

Controls	NULL
and	NULL
LPS-stimulated	NULL
samples	NULL
received	NULL
the	NULL
appropriate	NULL
amounts	NULL
of	NULL
VPLCK	NULL
.	NULL

Semiquantitative	NULL
reverse	NULL
transcription-polymerase	NULL
chain	NULL
reaction	NULL
analysis	NULL
mRNA	NULL
isolated	NULL
from	NULL
monocytes	NULL
(	NULL
0.5	NULL
X	NULL
10	NULL
%	NULL
cells/assay	NULL
)	NULL
with	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
s	NULL
magnetic	NULL
beads	NULL
was	NULL
analyzed	NULL
by	NULL
reverse	NULL
transcription-polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
RT-PCR	NULL
)	NULL
with	NULL
primers	NULL
specific	NULL
for	NULL
interleukin-1	NULL
«	NULL
(	NULL
IL-1a	NULL
)	NULL
,	NULL
IL-1	NULL
B	NULL
,	NULL
TNF-a	NULL
,	NULL
and	NULL
TF	NULL
Conditions	NULL
were	NULL
such	NULL
that	NULL
the	NULL
PCR	NULL
reactions	NULL
did	NULL
not	NULL
reach	NULL
the	NULL
saturation	NULL
phase	NULL
.	NULL

Control	NULL
experiments	NULL
showed	NULL
no	NULL
DNA	NULL
contaminations	NULL
.	NULL

Normalization	NULL
of	NULL
semiquantitative	NULL
PCR	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
HLA	NULL
(	NULL
B	NULL
)	NULL
as	NULL
an	NULL
internal	NULL
standard	NULL
.	NULL
``	NULL

''	NULL
The	NULL
identity	NULL
of	NULL
the	NULL
PCR	NULL
products	NULL
was	NULL
confirmed	NULL
by	NULL
direct	NULL
sequencing	NULL
(	NULL
Abi	NULL
Prism	NULL
310	NULL
;	NULL
Applied	NULL
Biosystems	NULL
,	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

For	NULL
determination	NULL
of	NULL
mRNA	NULL
stability	NULL
,	NULL
monocytes	NULL
were	NULL
stimulated	NULL
with	NULL
plasmin	NULL
(	NULL
1.43	NULL
CTA	NULL
U/mL	NULL
)	NULL
or	NULL
LPS	NULL
(	NULL
1	NULL
g/mL	NULL
)	NULL
for	NULL
4	NULL
hours	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
actinomycin	NULL
D	NULL
(	NULL
5	NULL
pg/mL	NULL
)	NULL
.	NULL

Levels	NULL
of	NULL
corresponding	NULL
cytokines	NULL
or	NULL
TF	NULL
mRNA	NULL
at	NULL
the	NULL
beginning	NULL
of	NULL
the	NULL
actinomycin	NULL
D	NULL
chase	NULL
(	NULL
time	NULL
point	NULL
,	NULL
0	NULL
hour	NULL
)	NULL
were	NULL
set	NULL
to	NULL
100	NULL
%	NULL
.	NULL

Curves	NULL
fitted	NULL
by	NULL
least-squares	NULL
regression	NULL
were	NULL
used	NULL
for	NULL
the	NULL
calculation	NULL
of	NULL
the	NULL
half-life	NULL
of	NULL
each	NULL
mRNA	NULL
.	NULL

Cytokine	NULL
and	NULL
TF	NULL
biosynthesis	NULL
Cytokines	NULL
were	NULL
assayed	NULL
in	NULL
cell-free	NULL
supernatants	NULL
using	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
ELISA	NULL
)	NULL
specific	NULL
for	NULL
IL-1	NULL
«	NULL
(	NULL
Cytimmune	NULL
;	NULL
College	NULL
BLOOD	NULL
,	NULL
15	NULL
JUNE	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
12	NULL
Park	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
IL-1B	NULL
,	NULL
interferon	NULL
(	NULL
IFN	NULL
)	NULL
-y	NULL
(	NULL
Biosource	NULL
,	NULL
Camarillo	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
TNF-a	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

TF	NULL
was	NULL
analyzed	NULL
in	NULL
whole	NULL
cell	NULL
extracts	NULL
using	NULL
a	NULL
TF-specific	NULL
ELISA	NULL
from	NULL
American	NULL
Diagnostica	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
monocytes	NULL
were	NULL
preincubated	NULL
for	NULL
15	NULL
minutes	NULL
with	NULL
cyclohexi-mide	NULL
(	NULL
10	NULL
g/mL	NULL
)	NULL
or	NULL
actinomycin	NULL
D	NULL
(	NULL
5	NULL
pg/mL	NULL
)	NULL
before	NULL
stimulation	NULL
with	NULL
1.43	NULL
CTA	NULL
U/mL	NULL
plasmin	NULL
for	NULL
8	NULL
hours	NULL
.	NULL

For	NULL
flow	NULL
cytometry	NULL
of	NULL
TF	NULL
expression	NULL
,	NULL
monocytes	NULL
plated	NULL
on	NULL
hydrophobic	NULL
Petriperm	NULL
dishes	NULL
(	NULL
In	NULL
Vitro	NULL
Systems	NULL
,	NULL
Osterode	NULL
,	NULL
Germany	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
plasmin	NULL
(	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
)	NULL
or	NULL
LPS	NULL
(	NULL
1	NULL
g/mL	NULL
)	NULL
for	NULL
8	NULL
hours	NULL
.	NULL

Cells	NULL
were	NULL
carefully	NULL
detached	NULL
by	NULL
scraping	NULL
.	NULL

Then	NULL
they	NULL
were	NULL
washed	NULL
with	NULL
15	NULL
mM	NULL
6-aminohexanoic	NULL
acid	NULL
and	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
to	NULL
remove	NULL
bound	NULL
plasmin	NULL
,	NULL
stained	NULL
with	NULL
either	NULL
monoclonal	NULL
antihuman	NULL
TF	NULL
or	NULL
control	NULL
MOPC21	NULL
and	NULL
anti-CD14	NULL
monoclonal	NULL
mouse	NULL
antibodies	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
FACScan	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
Monocytes	NULL
(	NULL
5	NULL
X	NULL
105	NULL
cells/assay	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
plasmin	NULL
(	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
)	NULL
or	NULL
LPS	NULL
(	NULL
1	NULL
g/mL	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
for	NULL
NFE-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
.	NULL
``	NULL

DNA-protein	NULL
interactions	NULL
were	NULL
assayed	NULL
by	NULL
incubating	NULL
5	NULL
ug	NULL
nuclear	NULL
extract	NULL
with	NULL
50000	NULL
cpm	NULL
labeled	NULL
double-stranded	NULL
NF-	NULL
«	NULL
B	NULL
site-specific	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
jg	NULL
poly	NULL
[	NULL
dI-dC	NULL
]	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
in	NULL
20	NULL
L	NULL
binding	NULL
buffer	NULL
,	NULL
pH	NULL
5.0	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCI	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1.0	NULL
mM	NULL
EDTA	NULL
,	NULL
40	NULL
mM	NULL
NaCl	NULL
,	NULL
1.0	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
and	NULL
4.0	NULL
mM	NULL
MgCl	NULL
;	NULL
)	NULL
at	NULL
24°C	NULL
for	NULL
30	NULL
minutes	NULL
.	NULL

AP-1	NULL
EMSA	NULL
was	NULL
assayed	NULL
as	NULL
described	NULL
``	NULL
except	NULL
for	NULL
10	NULL
%	NULL
glycerol	NULL
in	NULL
the	NULL
buffer	NULL
.	NULL

In	NULL
supershift	NULL
experiments	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
corresponding	NULL
antibodies	NULL
(	NULL
2	NULL
g	NULL
)	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
4°C	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
P-end	NULL
labeled	NULL
NF-xB	NULL
DNA	NULL
or	NULL
for	NULL
12	NULL
hours	NULL
at	NULL
4°C	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
P-labeled	NULL
AP-1	NULL
probe	NULL
.	NULL
``	NULL

Western	NULL
blot	NULL
analysis	NULL
and	NULL
immunostaining	NULL
Monocytes	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
cells/assay	NULL
)	NULL
were	NULL
cultured	NULL
on	NULL
hydrophobic	NULL
Petriperm	NULL
membranes	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
plasmin	NULL
(	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
)	NULL
or	NULL
LPS	NULL
(	NULL
1	NULL
g/mL	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
in	NULL
30	NULL
L	NULL
PBS	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
containing	NULL
1	NULL
%	NULL
Igepal	NULL
CA-630	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
0.5	NULL
%	NULL
Na-deoxycholate	NULL
,	NULL
0.1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
,	NULL
and	NULL
0.3	NULL
L	NULL
protease	NULL
inhibitor	NULL
cocktail	NULL
set	NULL
III	NULL
(	NULL
Calbiochem	NULL
)	NULL
.	NULL

Samples	NULL
containing	NULL
equal	NULL
amounts	NULL
of	NULL
protein	NULL
were	NULL
resolved	NULL
by	NULL
10	NULL
%	NULL
SDS	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
PAGE	NULL
)	NULL
and	NULL
electroblotted	NULL
onto	NULL
nitrocellulose	NULL
membranes	NULL
.	NULL

Membranes	NULL
were	NULL
incubated	NULL
with	NULL
appropriate	NULL
antibodies	NULL
(	NULL
1	NULL
pg/mL	NULL
)	NULL
and	NULL
subsequently	NULL
with	NULL
secondary	NULL
antibodies	NULL
conjugated	NULL
with	NULL
horseradish	NULL
peroxi-dase	NULL
(	NULL
1:1000	NULL
)	NULL
.	NULL

Antibody	NULL
complexes	NULL
were	NULL
visualized	NULL
using	NULL
the	NULL
enhanced	NULL
chemiluminescence	NULL
Western	NULL
blotting	NULL
detection	NULL
reagent	NULL
system	NULL
(	NULL
ECL	NULL
;	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
,	NULL
Buckinghamshire	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
and	NULL
subsequent	NULL
exposure	NULL
to	NULL
Hyperfilm	NULL
ECL	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
kinase	NULL
assay	NULL
Monocytes	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
cells/assay	NULL
)	NULL
were	NULL
lysed	NULL
with	NULL
500	NULL
L	NULL
buffer	NULL
,	NULL
pH	NULL
8.0	NULL
(	NULL
25	NULL
mM	NULL
Tris-HCI	NULL
,	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
25	NULL
mM	NULL
B-glycerophosphate	NULL
,	NULL
100	NULL
M	NULL
Na-orthovanadate	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
2	NULL
mM	NULL
EGTA	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
5	NULL
L	NULL
protease	NULL
inhibitor	NULL
cocktail	NULL
set	NULL
III	NULL
[	NULL
Calbiochem	NULL
]	NULL
)	NULL
,	NULL
and	NULL
supernatants	NULL
were	NULL
precleared	NULL
by	NULL
incubation	NULL
with	NULL
1	NULL
pg	NULL
normal	NULL
rabbit	NULL
IgG	NULL
and	NULL
10	NULL
pL	NULL
protein	NULL
A-agarose	NULL
.	NULL

For	NULL
immunoprecipitation	NULL
of	NULL
IKKa	NULL
and	NULL
IKK	NULL
$	NULL
,	NULL
precleared	NULL
cell	NULL
lysates	NULL
were	NULL
further	NULL
incubated	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
4°C	NULL
with	NULL
1	NULL
g	NULL
anti-IKKa	NULL
or	NULL
rabbit	NULL
polyclonal	NULL
antibodies	NULL
.	NULL

Afterward	NULL
,	NULL
10	NULL
L	NULL
protein	NULL
A-agarose	NULL
was	NULL
added	NULL
,	NULL
and	NULL
incubations	NULL
were	NULL
continued	NULL
for	NULL
1	NULL
hour	NULL
.	NULL

IKKs	NULL
attached	NULL
to	NULL
the	NULL
agarose	NULL
beads	NULL
were	NULL
extensively	NULL
washed	NULL
and	NULL
finally	NULL
resuspended	NULL
in	NULL
15	NULL
pL	NULL
kinase	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
10	NULL
mM	NULL
MgCl	NULL
;	NULL
,	NULL
20	NULL
mM	NULL
B-glycerophosphate	NULL
,	NULL
100	NULL
wM	NULL
Na-orthovanadate	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
)	NULL
.	NULL

Fifteen	NULL
microliters	NULL
IKK	NULL
,	NULL
10	NULL
wM	NULL
adenosine	NULL
triphosphate	NULL
(	NULL
ATP	NULL
)	NULL
,	NULL
and	NULL
5	NULL
Ci	NULL
(	NULL
6000	NULL
Ci/mmol	NULL
,	NULL
10	NULL
mCi/mL	NULL
;	NULL
Amersham	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
substrate	NULL
IxBa	NULL
(	NULL
1	NULL
wg	NULL
)	NULL
tagged	NULL
fusion	NULL
protein	NULL
corresponding	NULL
to	NULL
the	NULL
full-length	NULL
IxBa	NULL
(	NULL
amino	NULL
acids	NULL
1-317	NULL
)	NULL
of	NULL
human	NULL
origin	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
at	NULL
30°C	NULL
for	NULL
20	NULL
minutes	NULL
.	NULL

Samples	NULL
were	NULL
resolved	NULL
by	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
,	NULL
blotted	NULL
on	NULL
nitrocellulose	NULL
,	NULL
visualized	NULL
by	NULL
autoradiography	NULL
,	NULL
and	NULL
quantified	NULL
using	NULL
a	NULL
PhosphorImager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

To	NULL
check	NULL
loading	NULL
and	NULL
for	NULL
confirmation	NULL
of	NULL
IKK	NULL
immunoprecipitation	NULL
,	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
JUNE	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
12	NULL
blots	NULL
were	NULL
immunostained	NULL
with	NULL
1:500	NULL
dilutions	NULL
of	NULL
IKKa	NULL
or	NULL
IKKB	NULL
mouse	NULL
monoclonal	NULL
antibodies	NULL
,	NULL
respectively	NULL
.	NULL

Statistical	NULL
analysis	NULL
Values	NULL
shown	NULL
represent	NULL
mean	NULL
+	NULL
SEM	NULL
where	NULL
applicable	NULL
.	NULL

Statistical	NULL
significance	NULL
was	NULL
calculated	NULL
with	NULL
the	NULL
Newman-Keuls	NULL
test	NULL
.	NULL

Differences	NULL
were	NULL
considered	NULL
significant	NULL
for	NULL
P	NULL
<	NULL
.05	NULL
.	NULL

Results	NULL
Expression	NULL
of	NULL
cytokine	NULL
and	NULL
TF	NULL
mRNA	NULL
By	NULL
semiquantitative	NULL
RT-PCR	NULL
analysis	NULL
,	NULL
human	NULL
monocytes	NULL
did	NULL
not	NULL
express	NULL
detectable	NULL
cytokine	NULL
or	NULL
TF	NULL
mRNA	NULL
at	NULL
0	NULL
hour	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
.	NULL

Compared	NULL
with	NULL
controls	NULL
,	NULL
stimulation	NULL
of	NULL
monocytes	NULL
with	NULL
plasmin	NULL
(	NULL
1.43	NULL
CTA	NULL
U/mL	NULL
)	NULL
induced	NULL
the	NULL
time-dependent	NULL
expression	NULL
of	NULL
mRNA	NULL
for	NULL
IL-1a	NULL
,	NULL
IL-1	NULL
3	NULL
,	NULL
and	NULL
TNF-a	NULL
and	NULL
for	NULL
TF	NULL
(	NULL
Figure	NULL
1	NULL
A-B	NULL
)	NULL
.	NULL

All	NULL
4	NULL
mRNAs	NULL
investigated	NULL
followed	NULL
similar	NULL
kinetics	NULL
,	NULL
with	NULL
maximum	NULL
expression	NULL
4	NULL
hours	NULL
after	NULL
stimulation	NULL
and	NULL
a	NULL
slight	NULL
decrease	NULL
at	NULL
8	NULL
hours	NULL
.	NULL

IL-1	NULL
«	NULL
@	NULL
,	NULL
IL-1	NULL
,	NULL
and	NULL
TF	NULL
mRNA	NULL
expression	NULL
was	NULL
comparable	NULL
in	NULL
monocytes	NULL
stimulated	NULL
with	NULL
either	NULL
plasmin	NULL
or	NULL
LPS	NULL
,	NULL
though	NULL
the	NULL
kinetics	NULL
differed	NULL
.	NULL

Within	NULL
1	NULL
hour	NULL
of	NULL
1	NULL
pg/mL	NULL
LPS	NULL
stimulation	NULL
,	NULL
a	NULL
rapid	NULL
increase	NULL
of	NULL
mRNA	NULL
expression	NULL
occurred	NULL
,	NULL
whereas	NULL
mRNA	NULL
expression	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
plasmin	NULL
was	NULL
delayed	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
the	NULL
existing	NULL
literature	NULL
,	NULL
``	NULL
*	NULL
``	NULL
``	NULL
culture	NULL
of	NULL
the	NULL
monocytes	NULL
led	NULL
to	NULL
oc-	NULL
-.-e	NULL
ll	NULL
-	NULL
...	NULL
poe	NULL
eries	NULL
<	NULL
HLA	NULL
(	NULL
G	NULL
)	NULL
o	NULL
1	NULL
2	NULL
4	NULL
6	NULL
s	NULL
o	NULL
1	NULL
2	NULL
4	NULL
6	NULL
$	NULL
8	NULL
0	NULL
1	NULL
2	NULL
4	NULL
&	NULL
8	NULL
.	NULL

Time	NULL
(	NULL
h	NULL
)	NULL
Control	NULL
LPS	NULL
(	NULL
1	NULL
pg/mL	NULL
)	NULL
Plasmin	NULL
(	NULL
1.43	NULL
CTA	NULL
UimL	NULL
)	NULL
B	NULL
ILAa	NULL
_	NULL
IL18B	NULL
g	NULL
20	NULL
@	NULL
20	NULL
;	NULL
5	NULL
1s	NULL
Bis	NULL
B	NULL
€	NULL
a	NULL
18	NULL
<	NULL
10	NULL
2	NULL
2	NULL
€	NULL
£	NULL
gos	NULL
gas	NULL
&	NULL
*	NULL
&	NULL
a	NULL
00	NULL
5	NULL
an	NULL
3	NULL
-	NULL
4	NULL
L-	NULL
i	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
§	NULL
6	NULL
T	NULL
8	NULL
J	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
T	NULL
8	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
gas	NULL
TNFa	NULL
__	NULL
;	NULL
,	NULL
,	NULL
TF	NULL
.	NULL

§	NULL
5	NULL
20	NULL
{	NULL
*	NULL
&	NULL
Eu	NULL
c	NULL
<	NULL
3	NULL
&	NULL
10	NULL
gm	NULL
&	NULL
6	NULL
Fal	NULL
@	NULL
os	NULL
E	NULL
§	NULL
rrp	NULL
--	NULL
-	NULL
:	NULL
A	NULL
``	NULL
.	NULL

£	NULL
#	NULL
0	NULL
10	NULL
:	NULL
c	NULL
:	NULL
@	NULL
§	NULL
6	NULL
fos	NULL
00	NULL
4	NULL
r	NULL
a	NULL
4	NULL
50	NULL
%	NULL
foos	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
Figure	NULL
1	NULL
.	NULL

Plasmin	NULL
stimulates	NULL
time-dependent	NULL
expression	NULL
of	NULL
IL-1	NULL
,	NULL
IL-1	NULL
B	NULL
,	NULL
TNF-a	NULL
,	NULL
and	NULL
TF	NULL
mRNA	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

Monocytes	NULL
(	NULL
0.5	NULL
x	NULL
10®/mL	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
plasmin	NULL
1.43	NULL
CTA	NULL
U/mL	NULL
(	NULL
@	NULL
)	NULL
or	NULL
LPS	NULL
1	NULL
pg/mL	NULL
.	NULL

(	NULL
0	NULL
)	NULL
or	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
stimulus	NULL
(	NULL
C	NULL
]	NULL
)	NULL
.	NULL

At	NULL
indicated	NULL
times	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
mRNA	NULL
was	NULL
extracted	NULL
and	NULL
subjected	NULL
to	NULL
RT-PCR	NULL
.	NULL

HLA	NULL
(	NULL
B	NULL
)	NULL
was	NULL
used	NULL
for	NULL
normalization	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Representative	NULL
gels	NULL
are	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Semiquantitative	NULL
analysis	NULL
of	NULL
the	NULL
mRNA	NULL
expression	NULL
.	NULL

Results	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
5	NULL
independent	NULL
experiments	NULL
.	NULL

PLASMIN	NULL
INDUCTION	NULL
OF	NULL
CYTOKINES	NULL
_	NULL
3943	NULL
mRNA	NULL
expression	NULL
(	NULL
mRNA/HLA	NULL
(	NULL
B	NULL
)	NULL
mRNA	NULL
,	NULL
arbitrary	NULL
units	NULL
)	NULL
0	NULL
0.043	NULL
0.143	NULL
0.430	NULL
1.430	NULL
Plasmin	NULL
(	NULL
CTA	NULL
U/mL	NULL
)	NULL
Figure	NULL
2	NULL
.	NULL

Plasmin	NULL
triggers	NULL
concentration-dependent	NULL
expression	NULL
of	NULL
IL-1	NULL
«	NULL
,	NULL
IL-1B	NULL
,	NULL
TNF-a	NULL
,	NULL
and	NULL
TF	NULL
mRNA	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

Monocytes	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
LPS-free	NULL
plasmin	NULL
for	NULL
4	NULL
hours	NULL
.	NULL

Expression	NULL
of	NULL
mRNA	NULL
was	NULL
measured	NULL
by	NULL
semiquantitative	NULL
RT-PCR	NULL
.	NULL

HLA	NULL
(	NULL
B	NULL
)	NULL
was	NULL
used	NULL
for	NULL
normalization	NULL
.	NULL

Results	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
5	NULL
independent	NULL
experiments	NULL
.	NULL

*P	NULL
<	NULL
.05	NULL
and	NULL
**P	NULL
<	NULL
.01.	NULL
versus	NULL
unstimulated	NULL
controls	NULL
.	NULL

weak	NULL
adherence-induced	NULL
gene	NULL
expression	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
.	NULL

Adhesion	NULL
of	NULL
monocytes	NULL
``	NULL
``	NULL
was	NULL
,	NULL
however	NULL
,	NULL
not	NULL
promoted	NULL
by	NULL
plasmin	NULL
(	NULL
0.43	NULL
to	NULL
1.43	NULL
CTA	NULL
U/mL	NULL
)	NULL
,	NULL
nor	NULL
did	NULL
it	NULL
induce	NULL
homotypic	NULL
aggregation	NULL
as	NULL
measured	NULL
by	NULL
either	NULL
spectrophotometric	NULL
aggregometry	NULL
``	NULL
``	NULL
or	NULL
flow	NULL
cytometric	NULL
doublet	NULL
discrimination	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
plasmin-induced	NULL
changes	NULL
in	NULL
mRNA	NULL
expression	NULL
are	NULL
not	NULL
secondary	NULL
to	NULL
any	NULL
such	NULL
events	NULL
.	NULL

RT-PCR	NULL
products	NULL
had	NULL
the	NULL
expected	NULL
molecular	NULL
weights	NULL
and	NULL
were	NULL
identified	NULL
by	NULL
sequencing	NULL
.	NULL

Each	NULL
PCR	NULL
band	NULL
represented	NULL
a	NULL
single	NULL
PCR	NULL
product	NULL
,	NULL
with	NULL
more	NULL
than	NULL
99	NULL
%	NULL
sequence	NULL
identity	NULL
with	NULL
the	NULL
investigated	NULL
cytokine	NULL
or	NULL
TF	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Plasmin	NULL
triggered	NULL
a	NULL
concentration-dependent	NULL
expression	NULL
of	NULL
IL-1a	NULL
@	NULL
,	NULL
IL-1	NULL
,	NULL
TNF-a	NULL
@	NULL
,	NULL
and	NULL
TF	NULL
mRNA	NULL
in	NULL
monocytes	NULL
incubated	NULL
for	NULL
4	NULL
hours	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
unstimulated	NULL
controls	NULL
expressed	NULL
only	NULL
small	NULL
amounts	NULL
of	NULL
cytokine	NULL
and	NULL
TF	NULL
mRNA	NULL
.	NULL

Although	NULL
0.043	NULL
CTA	NULL
U/mL	NULL
plasmin	NULL
already	NULL
increased	NULL
IL-1	NULL
«	NULL
,	NULL
IL-1	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
and	NULL
TF	NULL
mRNA	NULL
expression	NULL
,	NULL
increases	NULL
were	NULL
significant	NULL
at	NULL
0.143	NULL
CTA	NULL
U/mL	NULL
plasmin	NULL
(	NULL
n	NULL
=	NULL
5	NULL
;	NULL
P	NULL
<	NULL
.05	NULL
vs	NULL
unstimulated	NULL
controls	NULL
)	NULL
.	NULL

The	NULL
concentration	NULL
of	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
plasmin	NULL
appeared	NULL
to	NULL
be	NULL
optimal	NULL
for	NULL
cytokine	NULL
expression	NULL
because	NULL
there	NULL
was	NULL
almost	NULL
no	NULL
further	NULL
mRNA	NULL
augmentation	NULL
with	NULL
plasmin	NULL
1.43	NULL
CTA	NULL
U/mL	NULL
.	NULL

Consistent	NULL
with	NULL
previous	NULL
studies	NULL
,	NULL
up	NULL
to	NULL
1.43	NULL
CTA	NULL
U/mL	NULL
plasmin	NULL
for	NULL
8	NULL
hours	NULL
did	NULL
not	NULL
alter	NULL
monocyte	NULL
viability	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
trypan	NULL
blue	NULL
dye	NULL
exclusion	NULL
,	NULL
nor	NULL
did	NULL
it	NULL
induce	NULL
apoptosis	NULL
in	NULL
terms	NULL
of	NULL
annexin	NULL
V	NULL
binding	NULL
to	NULL
externalized	NULL
phosphatidylserine	NULL
.	NULL
``	NULL

''	NULL
By	NULL
contrast	NULL
,	NULL
UV	NULL
(	NULL
254	NULL
nm	NULL
,	NULL
150	NULL
J/m	NULL
?	NULL
)	NULL

-irradiated	NULL
monocytes	NULL
stained	NULL
positive	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

An	NULL
intact	NULL
plasmin	NULL
catalytic	NULL
center	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
effects	NULL
observed	NULL
because	NULL
active	NULL
site-blocked	NULL
plasmin	NULL
was	NULL
unable	NULL
to	NULL
trigger	NULL
either	NULL
mRNA	NULL
expression	NULL
(	NULL
Figure	NULL
3A	NULL
)	NULL
or	NULL
corresponding	NULL
protein	NULL
release	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
plasmin	NULL
inhibitor	NULL
VPLCK	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
mRNA	NULL
expression	NULL
in	NULL
untreated	NULL
or	NULL
LPS-stimulated	NULL
monocytes	NULL
(	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
lysine	NULL
analogue	NULL
t-AMCA	NULL
(	NULL
3.0	NULL
mM	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
LPS-stimulated	NULL
mRNA	NULL
expression	NULL
,	NULL
nor	NULL
did	NULL
it	NULL
modulate	NULL
basal	NULL
control	NULL
expression	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
t-AMCA	NULL
at	NULL
0.3	NULL
and	NULL
3.0	NULL
mM	NULL
induced	NULL
a	NULL
concentration-dependent	NULL
inhibition	NULL
of	NULL
plasmin-induced	NULL
mRNA	NULL
expression	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
,	NULL
implying	NULL
the	NULL
necessity	NULL
of	NULL
the	NULL
plasmin	NULL
molecule	NULL
to	NULL
bind	NULL
through	NULL
its	NULL
lysine-binding	NULL
sites	NULL
.	NULL

Effects	NULL
of	NULL
plasmin	NULL
on	NULL
mRNA	NULL
stability	NULL
were	NULL
investigated	NULL
by	NULL
monitoring	NULL
the	NULL
decay	NULL
of	NULL
cytokine	NULL
and	NULL
TF	NULL
mRNA	NULL
in	NULL
monocytes	NULL
stimulated	NULL
with	NULL
plasmin	NULL
(	NULL
1.43	NULL
CTA	NULL
U/mL	NULL
)	NULL
or	NULL
LPS	NULL
(	NULL
1	NULL
pg/mL	NULL
)	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3944	NULL
_	NULL
SYROVETS	NULL
etal	NULL
A	NULL
»	NULL
X	NULL
6	NULL
A	NULL
x0	NULL
so	NULL
00660	NULL
s	NULL
qqé	NULL
6	NULL
g	NULL
«	NULL
we	NULL
g	NULL
w	NULL
g	NULL
w	NULL
6	NULL
A	NULL
``	NULL
&	NULL
We	NULL
W	NULL
C	NULL
,8C	NULL
C	NULL
,	NULL
.8	NULL
,	NULL
@	NULL
®	NULL
e	NULL
{	NULL
ZN	NULL
s*	NULL
``	NULL
°\	NULL
o	NULL
*	NULL
\°¥	NULL
x*	NULL
6	NULL
x	NULL
®	NULL
``	NULL
C	NULL
ye	NULL
``	NULL
s*	NULL
Figure	NULL
3	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
intact	NULL
catalytic	NULL
center	NULL
and	NULL
lysine	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
plasmin-induced	NULL
expression	NULL
of	NULL
IL-1	NULL
«	NULL
,	NULL
IL-1B	NULL
,	NULL
TNF-a	NULL
,	NULL
and	NULL
TF	NULL
mRNA	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Effect	NULL
of	NULL
active	NULL
site-blocked	NULL
plasmin	NULL
.	NULL

The	NULL
catalytic	NULL
center	NULL
of	NULL
plasmin	NULL
was	NULL
blocked	NULL
by	NULL
preincubation	NULL
with	NULL
the	NULL
irreversible	NULL
inhibitor	NULL
VPLCK	NULL
.	NULL

Monocytes	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
stimulus	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
VPLCK	NULL
25	NULL
M	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
LPS	NULL
1	NULL
pg/mL	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
LPS	NULL
1	NULL
pg/mL	NULL
,	NULL
and	NULL
VPLCK	NULL
25	NULL
mM	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
plasmin	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
or	NULL
with	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
active	NULL
site-blocked	NULL
plasmin	NULL
(	NULL
VPLCK-plasmin	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Effects	NULL
of	NULL
t-AMCA	NULL
.	NULL

Monocytes	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
stimulus	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
t-AMCA	NULL
3	NULL
mM	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
LPS	NULL
1	NULL
ug/mL	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
LPS	NULL
1	NULL
pg/mL	NULL
,	NULL
and	NULL
t-AMCA	NULL
3.0	NULL
mM	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
plasmin	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
.	NULL

(	NULL
lane	NULL
5	NULL
)	NULL
and	NULL
with	NULL
plasmin	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
and	NULL
t-AMCA	NULL
0.3	NULL
mM	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
or	NULL
3.0	NULL
mM	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
both	NULL
experiments	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
after	NULL
4	NULL
hours	NULL
,	NULL
and	NULL
mRNA	NULL
was	NULL
extracted	NULL
and	NULL
subjected	NULL
to	NULL
RT-PCR	NULL
.	NULL

HLA	NULL
(	NULL
B	NULL
)	NULL
was	NULL
used	NULL
for	NULL
normalization	NULL
.	NULL

Results	NULL
of	NULL
1	NULL
of	NULL
3	NULL
experiments	NULL
are	NULL
shown	NULL
in	NULL
each	NULL
case	NULL
.	NULL

Exponential	NULL
regression	NULL
analysis	NULL
of	NULL
the	NULL
data	NULL
indicated	NULL
that	NULL
stimulation	NULL
with	NULL
plasmin	NULL
unexpectedly	NULL
reduced	NULL
the	NULL
stability	NULL
of	NULL
cytokine	NULL
and	NULL
TF	NULL
mRNA	NULL
compared	NULL
with	NULL
LPS	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
.	NULL

The	NULL
mRNA	NULL
half-life	NULL
in	NULL
plasmin-stimulated	NULL
monocytes	NULL
ranged	NULL
from	NULL
0.9	NULL
hours	NULL
for	NULL
IL-1	NULL
B	NULL
to	NULL
2.2	NULL
hours	NULL
for	NULL
IL-l1a	NULL
.	NULL

In	NULL
LPS-stimulated	NULL
cells	NULL
,	NULL
mRNA	NULL
half-life	NULL
varied	NULL
between	NULL
1.9	NULL
hours	NULL
for	NULL
TNF-	NULL
«	NULL
and	NULL
10.4	NULL
hours	NULL
for	NULL
IL-1a	NULL
.	NULL

Plasmin	NULL
stimulates	NULL
cytokine	NULL
release	NULL
and	NULL
TF	NULL
biosynthesis	NULL
Cytokine	NULL
mRNA	NULL
expression	NULL
does	NULL
not	NULL
inevitably	NULL
lead	NULL
to	NULL
transla-tion	NULL
.	NULL
``	NULL

''	NULL
Similar	NULL
to	NULL
LPS	NULL
,	NULL
plasmin	NULL
triggers	NULL
time-	NULL
and	NULL
concentration-dependent	NULL
release	NULL
of	NULL
IL-1	NULL
«	NULL
,	NULL
IL-1B	NULL
,	NULL
and	NULL
TNF-	NULL
«	NULL
from	NULL
monocytes	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
.	NULL

Cytokines	NULL
and	NULL
TF	NULL
were	NULL
detectable	NULL
as	NULL
early	NULL
as	NULL
2	NULL
to	NULL
4	NULL
hours	NULL
after	NULL
stimulation	NULL
.	NULL

Plasmin	NULL
at	NULL
0.43	NULL
and	NULL
1.43	NULL
CTA	NULL
U/mL	NULL
was	NULL
at	NULL
least	NULL
as	NULL
potent	NULL
as	NULL
1	NULL
pg/mL	NULL
LPS	NULL
with	NULL
respect	NULL
to	NULL
IL-1a	NULL
«	NULL
release	NULL
.	NULL

However	NULL
,	NULL
LPS	NULL
triggered	NULL
a	NULL
more	NULL
rapid	NULL
and	NULL
extensive	NULL
release	NULL
of	NULL
indicating	NULL
clear	NULL
differences	NULL
between	NULL
LPS-	NULL
and	NULL
plasmin-mediated	NULL
activation	NULL
of	NULL
monocytes	NULL
.	NULL

Although	NULL
the	NULL
release	NULL
of	NULL
TNF-a	NULL
BLOOD	NULL
,	NULL
15	NULL
JUNE	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
12	NULL
IL-ta	NULL
IL-18B	NULL
100	NULL
ano	NULL
€	NULL
é	NULL
$	NULL
]	NULL
[	NULL
&	NULL
g	NULL
10	NULL
g	NULL
10	NULL
B	NULL
a	NULL
3	NULL
3	NULL
0	NULL
1	NULL
2	NULL
3	NULL
A	NULL
0	NULL
1	NULL
2	NULL
ill	NULL
4	NULL
Time	NULL
of	NULL
actinomycin	NULL
D	NULL
chase	NULL
(	NULL
h	NULL
)	NULL
Time	NULL
of	NULL
actinomycin	NULL
D	NULL
chase	NULL
(	NULL
h	NULL
)	NULL
TNFa	NULL
TF	NULL
_	NULL
i	NULL
%	NULL
L	NULL
too	NULL
S	NULL
g	NULL
€	NULL
&	NULL
€	NULL
i	NULL
10	NULL
g	NULL
10	NULL
F	NULL
Fe	NULL
2	NULL
a	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
a	NULL
1	NULL
2	NULL
a	NULL
a	NULL
Time	NULL
of	NULL
actinomycin	NULL
D	NULL
chase	NULL
(	NULL
h	NULL
)	NULL
Time	NULL
of	NULL
actinomycin	NULL
D	NULL
chase	NULL
(	NULL
h	NULL
)	NULL
Figure	NULL
4	NULL
.	NULL

Stability	NULL
of	NULL
IL-1	NULL
«	NULL
,	NULL
IL-1B	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
and	NULL
TF	NULL
mRNA	NULL
in	NULL
plasmin-treated	NULL
monocytes	NULL
.	NULL

Monocytes	NULL
were	NULL
stimulated	NULL
for	NULL
4	NULL
hours	NULL
with	NULL
plasmin	NULL
1.43	NULL
CTA	NULL
U/mL	NULL
.	NULL

(	NULL
MN	NULL
)	NULL
or	NULL
LPS	NULL
1	NULL
g/mL	NULL
(	NULL
0	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
the	NULL
corresponding	NULL
cytokine	NULL
or	NULL
TF	NULL
mRNA	NULL
at	NULL
this	NULL
time	NULL
point	NULL
was	NULL
100	NULL
%	NULL
.	NULL

Actinomycin	NULL
D	NULL
(	NULL
5	NULL
g/mL	NULL
)	NULL
was	NULL
added	NULL
,	NULL
and	NULL
incubation	NULL
continued	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
.	NULL

Poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
was	NULL
isolated	NULL
and	NULL
subjected	NULL
to	NULL
RT-PCR	NULL
.	NULL

HLA	NULL
(	NULL
B	NULL
)	NULL
was	NULL
used	NULL
for	NULL
normalization	NULL
;	NULL
its	NULL
stability	NULL
over	NULL
4	NULL
hours	NULL
was	NULL
not	NULL
significantly	NULL
different	NULL
in	NULL
controls	NULL
than	NULL
in	NULL
plasmin-	NULL
or	NULL
LPS-treated	NULL
cells	NULL
.	NULL

Results	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
3	NULL
independent	NULL
experiments	NULL
.	NULL

Curves	NULL
were	NULL
fitted	NULL
by	NULL
least-squares	NULL
regression	NULL
analysis	NULL
and	NULL
were	NULL
used	NULL
to	NULL
calculate	NULL
the	NULL
half-life	NULL
of	NULL
each	NULL
mRNA	NULL
species	NULL
.	NULL

was	NULL
delayed	NULL
in	NULL
plasmin-stimulated	NULL
monocytes	NULL
,	NULL
at	NULL
2	NULL
hours	NULL
after	NULL
exposure	NULL
there	NULL
was	NULL
no	NULL
significant	NULL
difference	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
TNF-a	NULL
«	NULL
released	NULL
by	NULL
cells	NULL
stimulated	NULL
with	NULL
either	NULL
1.43	NULL
CTA	NULL
U/mL	NULL
plasmin	NULL
or	NULL
LPS	NULL
1	NULL
pg/mL	NULL
.	NULL

Similarly	NULL
,	NULL
TF	NULL
production	NULL
analyzed	NULL
in	NULL
whole-cell	NULL
extracts	NULL
commenced	NULL
with	NULL
some	NULL
delay	NULL
in	NULL
plasmin-treated	NULL
monocytes	NULL
;	NULL
however	NULL
,	NULL
at	NULL
6	NULL
to	NULL
8	NULL
hours	NULL
after	NULL
the	NULL
onset	NULL
of	NULL
stimulation	NULL
with	NULL
0.43	NULL
or	NULL
1.43	NULL
CTA	NULL
U/mL	NULL
plasmin	NULL
,	NULL
monocytes	NULL
generated	NULL
even	NULL
more	NULL
TF	NULL
than	NULL
LPS-stimulated	NULL
cells	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
.	NULL

Monocytes	NULL
pre-treated	NULL
with	NULL
inhibitors	NULL
of	NULL
transcription	NULL
(	NULL
5	NULL
pg/mL	NULL
actinomycin	NULL
D	NULL
)	NULL
or	NULL
IL-10	NULL
IL-18	NULL
14	NULL
*	NULL
-C-	NULL
LPS	NULL
-a-	NULL
Plasmin	NULL
(	NULL
1.43	NULL
CTA	NULL
UfmL	NULL
)	NULL
-	NULL
@	NULL
-	NULL
Plasmin	NULL
(	NULL
0.43	NULL
CTA	NULL
Wim	NULL
)	NULL
-A-	NULL
Plasmin	NULL
(	NULL
0.143	NULL
CTA	NULL
UimL	NULL
)	NULL
04	NULL
z	NULL
a	NULL
it	NULL
!	NULL

08	NULL
]	NULL
--	NULL
Plasmin	NULL
(	NULL
0.043	NULL
CTA	NULL
UimL	NULL
)	NULL
8	NULL
©	NULL
T	NULL
©	NULL
x	NULL
02	NULL
B	NULL
8	NULL
C	NULL
a	NULL
&	NULL
a	NULL
3	NULL
5	NULL
3	NULL
0.0	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
@	NULL
8	NULL
C	NULL
%	NULL
$	NULL
3	NULL
©	NULL
T	NULL
&	NULL
f	NULL
&	NULL
3	NULL
E	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
Figure	NULL
5	NULL
.	NULL

Generation	NULL
of	NULL
IL-1	NULL
,	NULL
IL-1B	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
and	NULL
TF	NULL
by	NULL
plasmin-stimulated	NULL
human	NULL
monocytes	NULL
.	NULL

Monocytes	NULL
were	NULL
incubated	NULL
with	NULL
various	NULL
concentrations	NULL
of	NULL
plasmin	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

Monocytes	NULL
treated	NULL
with	NULL
LPS	NULL
1	NULL
mg/mL	NULL
served	NULL
as	NULL
positive	NULL
controls	NULL
.	NULL

Supernatants	NULL
were	NULL
collected	NULL
,	NULL
and	NULL
the	NULL
release	NULL
of	NULL
IL-1	NULL
«	NULL
,	NULL
IL-1B	NULL
,	NULL
and	NULL
TNF-a	NULL
was	NULL
analyzed	NULL
by	NULL
ELISA	NULL
.	NULL

Cell-associated	NULL
TF	NULL
was	NULL
measured	NULL
in	NULL
whole-cell	NULL
lysates	NULL
.	NULL

Results	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
4	NULL
to	NULL
6	NULL
independent	NULL
experiments	NULL
.	NULL

*P	NULL
<	NULL
.05	NULL
and	NULL
**P	NULL
<	NULL
.01.	NULL
versus	NULL
unstimulated	NULL
controls	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
JUNE	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
12	NULL
translation	NULL
(	NULL
10	NULL
pg/mL	NULL
cycloheximide	NULL
)	NULL
produced	NULL
no	NULL
detectable	NULL
amounts	NULL
of	NULL
cytokines	NULL
or	NULL
TF	NULL
after	NULL
stimulation	NULL
with	NULL
1.43	NULL
CTA	NULL
U/mL	NULL
plasmin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

There	NULL
was	NULL
no	NULL
detectable	NULL
release	NULL
of	NULL
IFN-y	NULL
by	NULL
cultured	NULL
cells	NULL
at	NULL
any	NULL
of	NULL
the	NULL
time	NULL
points	NULL
investigated	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

TF	NULL
expression	NULL
is	NULL
up-regulated	NULL
in	NULL
plasmin-stimulated	NULL
monocytes	NULL
Flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
CD14*	NULL
cells	NULL
revealed	NULL
TF	NULL
expression	NULL
on	NULL
the	NULL
surfaces	NULL
of	NULL
plasmin-stimulated	NULL
monocytes	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
published	NULL
data	NULL
,	NULL
``	NULL
``	NULL
unstimulated	NULL
monocytes	NULL
expressed	NULL
only	NULL
low	NULL
levels	NULL
of	NULL
TF	NULL
.	NULL

Stimulation	NULL
with	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
plasmin	NULL
for	NULL
8	NULL
hours	NULL
led	NULL
to	NULL
significantly	NULL
increased	NULL
TF	NULL
expression	NULL
,	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
cells	NULL
stimulated	NULL
with	NULL
LPS	NULL
1	NULL
pg/mL	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
.	NULL

TF	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
in	NULL
supernatants	NULL
of	NULL
plasmin-stimulated	NULL
monocytes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
membrane-bound	NULL
TF	NULL
was	NULL
not	NULL
proteolyti-cally	NULL
released	NULL
by	NULL
plasmin	NULL
.	NULL

LPS-stimulated	NULL
cells	NULL
did	NULL
not	NULL
release	NULL
TF	NULL
either	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Plasmin	NULL
triggers	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
NF-kB	NULL
complex	NULL
NE-rB-binding	NULL
sites	NULL
are	NULL
present	NULL
in	NULL
the	NULL
promoter	NULL
regions	NULL
of	NULL
many	NULL
cytokine	NULL
genes	NULL
.	NULL
``	NULL

Transcription	NULL
of	NULL
the	NULL
TF	NULL
gene	NULL
is	NULL
also	NULL
strongly	NULL
dependent	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
NF-kB/Rel	NULL
proteins	NULL
.	NULL
``	NULL

Increased	NULL
binding	NULL
of	NULL
nuclear	NULL
extracts	NULL
to	NULL
an	NULL
NF-kB	NULL
DNA	NULL
probe	NULL
was	NULL
observed	NULL
as	NULL
early	NULL
as	NULL
10	NULL
minutes	NULL
after	NULL
stimulation	NULL
of	NULL
monocytes	NULL
with	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
plasmin	NULL
;	NULL
it	NULL
reached	NULL
a	NULL
maximum	NULL
at	NULL
1	NULL
hour	NULL
and	NULL
declined	NULL
after	NULL
2	NULL
hours	NULL
(	NULL
Figure	NULL
7A	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
time-course	NULL
of	NULL
NF-kB	NULL
activation	NULL
was	NULL
found	NULL
in	NULL
LPS-stimulated	NULL
monocytes	NULL
,	NULL
though	NULL
the	NULL
DNA-binding	NULL
activity	NULL
was	NULL
stronger	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
NF-kB	NULL
binding	NULL
was	NULL
confirmed	NULL
in	NULL
competition	NULL
experiments	NULL
;	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
NF-B	NULL
,	NULL
but	NULL
not	NULL
of	NULL
AP-2	NULL
consensus	NULL
oligonucleotides	NULL
,	NULL
abolished	NULL
binding	NULL
of	NULL
the	NULL
nuclear	NULL
extracts	NULL
to	NULL
the	NULL
labeled	NULL
site	NULL
sequence	NULL
(	NULL
Figure	NULL
7B	NULL
)	NULL
.	NULL

The	NULL
protein	NULL
composition	NULL
of	NULL
the	NULL
DNA-protein	NULL
band	NULL
was	NULL
further	NULL
investigated	NULL
through	NULL
EMSA	NULL
.	NULL

Of	NULL
the	NULL
5	NULL
known	NULL
mammalian	NULL
NF-kB/Rel	NULL
proteins	NULL
,	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
p65	NULL
are	NULL
highly	NULL
expressed	NULL
in	NULL
monocytes	NULL
and	NULL
macrophages	NULL
;	NULL
a	NULL
high	NULL
expression	NULL
of	NULL
RelB	NULL
is	NULL
confined	NULL
to	NULL
maturing	NULL
and	NULL
differentiated	NULL
dendritic	NULL
cells	NULL
.	NULL

!	NULL

~	NULL
>	NULL
Stimulation	NULL
of	NULL
monocytes	NULL
with	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
plasmin	NULL
resulted	NULL
in	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
c-Rel	NULL
but	NULL
not	NULL
of	NULL
p52	NULL
(	NULL
Figure	NULL
7B	NULL
)	NULL
.	NULL

IkBa	NULL
and	NULL
p105	NULL
are	NULL
differentially	NULL
degraded	NULL
in	NULL
plasmin-	NULL
and	NULL
LPS-stimulated	NULL
monocytes	NULL
The	NULL
effect	NULL
of	NULL
plasmin	NULL
on	NULL
the	NULL
degradation	NULL
of	NULL
IxBa	NULL
was	NULL
analyzed	NULL
in	NULL
immunoblots	NULL
of	NULL
cell	NULL
extracts	NULL
.	NULL

Control	NULL
cells	NULL
showed	NULL
no	NULL
significant	NULL
LPS	NULL
Plasmin	NULL
s	NULL
s	NULL
a	NULL
#	NULL
3	NULL
5	NULL
O	NULL
C	NULL
a	NULL
o	NULL
10°	NULL
gol	NULL
ant	NULL
oan	NULL
qo	NULL
``	NULL
10°	NULL
ao	NULL
!	NULL

40	NULL
%	NULL
40°	NULL
as	NULL
``	NULL
Tissue	NULL
factor	NULL
Tissue	NULL
factor	NULL
Figure	NULL
6	NULL
.	NULL

Induction	NULL
of	NULL
TF	NULL
expression	NULL
on	NULL
the	NULL
monocyte	NULL
membrane	NULL
by	NULL
plasmin	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
TF	NULL
on	NULL
human	NULL
monocytes	NULL
incubated	NULL
for	NULL
8	NULL
hours	NULL
with	NULL
plasmin	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
(	NULL
black	NULL
}	NULL
,	NULL
LPS	NULL
1	NULL
g/mL	NULL
(	NULL
black	NULL
}	NULL
,	NULL
or	NULL
unstimulated	NULL
controls	NULL
(	NULL
gray	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
stained	NULL
with	NULL
unspecific	NULL
IgG	NULL
;	NULL
(	NULL
MOPC21	NULL
,	NULL
negative	NULL
control	NULL
,	NULL
white	NULL
)	NULL
and	NULL
antihuman	NULL
TF	NULL
antibodies	NULL
.	NULL

Binding	NULL
of	NULL
primary	NULL
antibodies	NULL
was	NULL
visualized	NULL
by	NULL
anti-mouse	NULL
IgG	NULL
PE-conjugated	NULL
secondary	NULL
antibodies	NULL
.	NULL

Results	NULL
of	NULL
1	NULL
of	NULL
3	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

PLASMIN	NULL
INDUCTION	NULL
OF	NULL
CYTOKINES	NULL
_	NULL
3945	NULL
A	NULL
Time	NULL
{	NULL
min	NULL
)	NULL
60	NULL
10	NULL
30	NULL
60	NULL
60	NULL
10	NULL
30	NULL
60	NULL
120	NULL
NFB	NULL
-	NULL
»	NULL
*a	NULL
dae	NULL
$	NULL
2	NULL
dap	NULL
+	NULL
>	NULL
L	NULL
7	NULL
L	NULL
)	NULL
Stimulus	NULL
=	NULL
LPS	NULL
(	NULL
1	NULL
pg/mL	NULL
)	NULL
-	NULL
_	NULL
Plasmin	NULL
(	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
)	NULL
B	NULL
p	NULL
£	NULL
®	NULL
ty	NULL
hir	NULL
c	NULL
4	NULL
#	NULL
supers	NULL
-__	NULL
``	NULL
_	NULL
_-	NULL
_-	NULL
#	NULL
``	NULL
#	NULL
$	NULL
333	NULL
:	NULL
C+	NULL
-	NULL
.	NULL

w	NULL
__	NULL
.	NULL

+	NULL
p50	NULL
NFB	NULL
»	NULL
#	NULL
#	NULL
+	NULL
i	NULL
Ww	NULL
Plasmin	NULL
=	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
Competitor	NULL
=	NULL
=	NULL
-	NULL
-	NULL
-	NULL
NFxB	NULL
-	NULL
AP2	NULL
Figure	NULL
7	NULL
.	NULL

NF-kB	NULL
activation	NULL
by	NULL
plasmin	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Kinetic	NULL
study	NULL
.	NULL

Monocytes	NULL
were	NULL
stimulated	NULL
with	NULL
plasmin	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
or	NULL
LPS	NULL
1	NULL
g/mL	NULL
(	NULL
positive	NULL
control	NULL
)	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
,	NULL
and	NULL
nuclei	NULL
were	NULL
isolated	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
EMSA	NULL
with	NULL
a	NULL
``	NULL
P-labeled	NULL
DNA	NULL
probe	NULL
containing	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Supershift	NULL
and	NULL
competition	NULL
study	NULL
.	NULL

Monocytes	NULL
were	NULL
stimulated	NULL
with	NULL
plasmin	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
for	NULL
1	NULL
hour	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
hour	NULL
with	NULL
anti-p65	NULL
,	NULL
anti-c-Rel	NULL
,	NULL
anti-p50	NULL
,	NULL
and	NULL
anti-p52	NULL
antibodies	NULL
or	NULL
with	NULL
unlabeled	NULL
NF-	NULL
«	NULL
B	NULL
or	NULL
AP-2	NULL
specific	NULL
oligonucleotides	NULL
(	NULL
100-fold	NULL
molar	NULL
excess	NULL
)	NULL
.	NULL

Supershift	NULL
assay	NULL
revealed	NULL
binding	NULL
of	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
p50	NULL
,	NULL
but	NULL
not	NULL
of	NULL
p52	NULL
nuclear	NULL
factor	NULL
.	NULL

Preincubation	NULL
with	NULL
NF-	NULL
«	NULL
B-specific	NULL
oligonucleotide	NULL
sequence	NULL
abolished	NULL
formation	NULL
of	NULL
the	NULL
NF-kB	NULL
complex	NULL
.	NULL

AP-2-specific	NULL
oligonucleotides	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
NF-kB/DNA	NULL
complex	NULL
formation	NULL
.	NULL

Results	NULL
of	NULL
1	NULL
of	NULL
3	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

changes	NULL
in	NULL
IxBa	NULL
protein	NULL
during	NULL
2	NULL
hours	NULL
(	NULL
Figure	NULL
8A	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
monocytes	NULL
with	NULL
1	NULL
pg/mL	NULL
LPS	NULL
for	NULL
10	NULL
minutes	NULL
was	NULL
sufficient	NULL
for	NULL
the	NULL
rapid	NULL
degradation	NULL
of	NULL
IxBa	NULL
.	NULL

By	NULL
30	NULL
minutes	NULL
,	NULL
only	NULL
30	NULL
%	NULL
of	NULL
the	NULL
initially	NULL
present	NULL
IxBa	NULL
was	NULL
detectable	NULL
.	NULL

However	NULL
,	NULL
1	NULL
hour	NULL
after	NULL
stimulation	NULL
,	NULL
the	NULL
level	NULL
of	NULL
IxBa	NULL
started	NULL
to	NULL
increase	NULL
and	NULL
reached	NULL
almost	NULL
the	NULL
initial	NULL
level	NULL
by	NULL
2	NULL
hours	NULL
.	NULL

The	NULL
degradation	NULL
of	NULL
IxBa	NULL
«	NULL
in	NULL
monocytes	NULL
stimulated	NULL
with	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
plasmin	NULL
was	NULL
delayed	NULL
.	NULL

Proteolysis	NULL
of	NULL
IxBa	NULL
was	NULL
detectable	NULL
after	NULL
10	NULL
minutes	NULL
,	NULL
but	NULL
almost	NULL
complete	NULL
(	NULL
80	NULL
%	NULL
)	NULL
degradation	NULL
was	NULL
not	NULL
observed	NULL
until	NULL
after	NULL
1	NULL
hour	NULL
.	NULL

As	NULL
in	NULL
LPS-stimulated	NULL
cells	NULL
,	NULL
2	NULL
hours	NULL
after	NULL
plasmin	NULL
stimulation	NULL
IxBa	NULL
returned	NULL
almost	NULL
to	NULL
its	NULL
initial	NULL
level	NULL
.	NULL

This	NULL
normalization	NULL
of	NULL
IKBa	NULL
coincided	NULL
with	NULL
the	NULL
decrease	NULL
of	NULL
NF-kB	NULL
binding	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
EMSA	NULL
(	NULL
Figure	NULL
7A	NULL
)	NULL
.	NULL

Proteolytic	NULL
degradation	NULL
of	NULL
p105	NULL
,	NULL
a	NULL
cytoplasmic	NULL
inhibitor	NULL
of	NULL
NE-	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
nuclear	NULL
factors	NULL
and	NULL
a	NULL
putative	NULL
precursor	NULL
of	NULL
p50	NULL
,	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
cell	NULL
activation	NULL
.	NULL

``	NULL
``	NULL
``	NULL
°	NULL
Levels	NULL
of	NULL
p50	NULL
and	NULL
p105	NULL
were	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
.	NULL

Antibodies	NULL
directed	NULL
against	NULL
p50	NULL
also	NULL
recognized	NULL
p105	NULL
.	NULL

There	NULL
were	NULL
no	NULL
changes	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
p50	NULL
or	NULL
p105	NULL
in	NULL
control	NULL
cells	NULL
(	NULL
Figure	NULL
8B	NULL
)	NULL
.	NULL

Stimulation	NULL
with	NULL
1	NULL
pg/mL	NULL
LPS	NULL
caused	NULL
partial	NULL
degradation	NULL
of	NULL
p105	NULL
,	NULL
with	NULL
approximately	NULL
50	NULL
%	NULL
reduction	NULL
at	NULL
2	NULL
hours	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
stimulation	NULL
of	NULL
monocytes	NULL
with	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
plasmin	NULL
almost	NULL
resulted	NULL
in	NULL
the	NULL
disappearance	NULL
of	NULL
the	NULL
p105	NULL
band	NULL
10	NULL
minutes	NULL
after	NULL
stimulation	NULL
(	NULL
Figure	NULL
8B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
this	NULL
degradation	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
an	NULL
accumulation	NULL
of	NULL
the	NULL
p50	NULL
product	NULL
,	NULL
indicating	NULL
that	NULL
plasmin	NULL
induces	NULL
the	NULL
proteolysis	NULL
of	NULL
p105	NULL
but	NULL
not	NULL
of	NULL
its	NULL
processing	NULL
to	NULL
p50	NULL
.	NULL

The	NULL
profound	NULL
effect	NULL
of	NULL
plasmin	NULL
stimulation	NULL
on	NULL
p105	NULL
degradation	NULL
was	NULL
studied	NULL
in	NULL
greater	NULL
detail	NULL
(	NULL
Figure	NULL
8C	NULL
)	NULL
.	NULL

Plasmin	NULL
0.043	NULL
to	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
induced	NULL
a	NULL
concentration-dependent	NULL
proteolysis	NULL
of	NULL
p105	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
time	NULL
dependence	NULL
between	NULL
0	NULL
and	NULL
20	NULL
minutes	NULL
revealed	NULL
proteolytic	NULL
degradation	NULL
as	NULL
early	NULL
as	NULL
2	NULL
minutes	NULL
after	NULL
plasmin	NULL
stimulation	NULL
and	NULL
confirmed	NULL
the	NULL
maximum	NULL
effect	NULL
at	NULL
10	NULL
minutes	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3946	NULL
-	NULL
SYROVETS	NULL
etal	NULL
A	NULL
Control	NULL
-	NULL
aie	NULL
apatite	NULL
+	NULL
LPS	NULL
L	NULL
A	NULL
``	NULL
``	NULL
He	NULL
s	NULL
IxBa	NULL
Plasmin	NULL
CUs	NULL
.	NULL

wam	NULL
dito	NULL
~~~	NULL
sD	NULL
=	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
0	NULL
10	NULL
30	NULL
60	NULL
120	NULL
B	NULL
4	NULL
p105	NULL
Control	NULL
«	NULL
#	NULL
tmmemmmm	NULL
mri	NULL
:	NULL
PA	NULL
:	NULL
KE	NULL
:	NULL
4-	NULL
$	NULL
SO	NULL
commence	NULL
«	NULL
mmap	NULL
4	NULL
D105	NULL
LPS	NULL
seem	NULL
«	NULL
rine	NULL
aer	NULL
er	NULL
«	NULL
eee	NULL
tits	NULL
*~	NULL
©	NULL
|	NULL
nicuices	NULL
ﬂ	NULL
<	NULL
4-	NULL
p105	NULL
Plasmin	NULL
<	NULL
a	NULL
>	NULL
«	NULL
sx	NULL
»	NULL
TP	NULL
*+	NULL
VV	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
0	NULL
10	NULL
30	NULL
60	NULL
120	NULL
C	NULL
hir	NULL
ite	NULL
ame	NULL
cam	NULL
WP	NULL
+	NULL
p105	NULL
0.143	NULL
CTA	NULL
Uml	NULL
s	NULL
ie	NULL
ee	NULL
somme	NULL
.	NULL

<	NULL
-	NULL
P105	NULL
0.43	NULL
CTA	NULL
UImL	NULL
|	NULL
|	NULL
«	NULL
Witte	NULL
-	NULL
aie	NULL
woes	NULL
»	NULL
<	NULL
-	NULL
p105	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
0	NULL
q	NULL
5	NULL
10	NULL
20	NULL
Figure	NULL
8	NULL
.	NULL

Proteolytic	NULL
degradation	NULL
of	NULL
IkBa	NULL
and	NULL
p105	NULL
in	NULL
plasmin-stimulated	NULL
monocytes	NULL
.	NULL

(	NULL
A	NULL
,	NULL
B	NULL
)	NULL
Kinetic	NULL
study	NULL
.	NULL

Cells	NULL
were	NULL
either	NULL
unstimulated	NULL
(	NULL
control	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
LPS	NULL
1	NULL
g/mL	NULL
(	NULL
positive	NULL
control	NULL
)	NULL
or	NULL
plasmin	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Detailed	NULL
time-	NULL
and	NULL
concentration-dependent	NULL
effects	NULL
of	NULL
plasmin	NULL
from	NULL
0.043	NULL
to	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
on	NULL
p105	NULL
degradation	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
used	NULL
for	NULL
immunoblots	NULL
with	NULL
specific	NULL
anti-lkB	NULL
«	NULL
(	NULL
A	NULL
)	NULL
and	NULL
anti-p50	NULL
(	NULL
B	NULL
,	NULL
C	NULL
)	NULL
antibodies	NULL
.	NULL

Because	NULL
p105	NULL
contains	NULL
the	NULL
complete	NULL
sequence	NULL
of	NULL
p50	NULL
,	NULL
it	NULL
is	NULL
also	NULL
recognized	NULL
by	NULL
anti-p50	NULL
antibodies	NULL
.	NULL

Positions	NULL
of	NULL
IkBa	NULL
«	NULL
(	NULL
37	NULL
kd	NULL
)	NULL
,	NULL
p105	NULL
and	NULL
p50	NULL
(	NULL
105	NULL
kd	NULL
and	NULL
50	NULL
kd	NULL
,	NULL
respectively	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
a	NULL
representative	NULL
blot	NULL
of	NULL
3	NULL
independent	NULL
experiments	NULL
is	NULL
shown	NULL
.	NULL

Differential	NULL
activation	NULL
of	NULL
IKKa	NULL
and	NULL
IKKB	NULL
Lysis	NULL
of	NULL
the	NULL
monocytes	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
disrupts	NULL
the	NULL
integrity	NULL
of	NULL
the	NULL
signalsome	NULL
complex	NULL
``	NULL
?	NULL

and	NULL
thus	NULL
allows	NULL
separate	NULL
analysis	NULL
of	NULL
IKKa	NULL
and	NULL
IKK	NULL
activities	NULL
after	NULL
immunoprecipitation	NULL
of	NULL
the	NULL
IxB	NULL
kinases	NULL
from	NULL
the	NULL
cellular	NULL
extracts	NULL
.	NULL

The	NULL
protein	NULL
composition	NULL
of	NULL
the	NULL
precipitates	NULL
was	NULL
analyzed	NULL
,	NULL
and	NULL
homogeneity	NULL
and	NULL
equal	NULL
sample	NULL
distribution	NULL
were	NULL
confirmed	NULL
by	NULL
immunoblot	NULL
analysis	NULL
with	NULL
anti-IKKa	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
anti-IKKfB	NULL
antibodies	NULL
(	NULL
Figure	NULL
9A	NULL
)	NULL
.	NULL

IKK	NULL
assays	NULL
revealed	NULL
that	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
unstimulated	NULL
cells	NULL
,	NULL
monocytes	NULL
stimulated	NULL
with	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
plasmin	NULL
elicited	NULL
rapid	NULL
activation	NULL
of	NULL
IKKB	NULL
detectable	NULL
within	NULL
10	NULL
minutes	NULL
.	NULL

IKKB	NULL
activity	NULL
peaked	NULL
at	NULL
1	NULL
hour	NULL
and	NULL
decreased	NULL
by	NULL
2	NULL
hours	NULL
,	NULL
indicating	NULL
the	NULL
transient	NULL
character	NULL
of	NULL
the	NULL
activation	NULL
(	NULL
Figure	NULL
9A	NULL
)	NULL
.	NULL

LPS	NULL
(	NULL
1	NULL
g/mL	NULL
)	NULL
was	NULL
a	NULL
more	NULL
potent	NULL
activator	NULL
of	NULL
IKKB	NULL
and	NULL
led	NULL
to	NULL
approximately	NULL
100-fold	NULL
activation	NULL
within	NULL
10	NULL
minutes	NULL
(	NULL
Figure	NULL
9B	NULL
)	NULL
.	NULL

Plasmin	NULL
did	NULL
not	NULL
affect	NULL
IKKa	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
JUNE	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
12	NULL
Plasmin	NULL
triggers	NULL
activation	NULL
of	NULL
AP-1	NULL
Nuclear	NULL
proteins	NULL
from	NULL
monocytes	NULL
stimulated	NULL
for	NULL
2	NULL
hours	NULL
with	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
plasmin	NULL
were	NULL
subjected	NULL
to	NULL
EMSA	NULL
with	NULL
a	NULL
DNA	NULL
probe	NULL
containing	NULL
the	NULL
AP-1	NULL
binding	NULL
site	NULL
.	NULL

Plasmin	NULL
induced	NULL
strong	NULL
binding	NULL
to	NULL
the	NULL
AP-1	NULL
probe	NULL
(	NULL
Figure	NULL
10A	NULL
)	NULL
.	NULL

Binding	NULL
specificity	NULL
was	NULL
confirmed	NULL
using	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
AP-1	NULL
and	NULL
nonspecific	NULL
SP-1	NULL
probes	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
Fos/Jun	NULL
proteins	NULL
involved	NULL
in	NULL
the	NULL
plasmin-induced	NULL
AP-1	NULL
DNA	NULL
binding	NULL
in	NULL
human	NULL
monocytes	NULL
was	NULL
characterized	NULL
in	NULL
supershift	NULL
assays	NULL
with	NULL
specific	NULL
antibodies	NULL
(	NULL
Figure	NULL
10B	NULL
)	NULL
.	NULL

Anti-c-Fos	NULL
induced	NULL
a	NULL
slight	NULL
supershift	NULL
,	NULL
whereas	NULL
anti-FosB	NULL
induced	NULL
a	NULL
stronger	NULL
supershift	NULL
.	NULL

The	NULL
AP-1	NULL
shift	NULL
was	NULL
also	NULL
strongly	NULL
retarded	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-JunD	NULL
,	NULL
but	NULL
not	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
JunB	NULL
,	NULL
FRA-1	NULL
,	NULL
or	NULL
FRA-2	NULL
antibodies	NULL
(	NULL
Figure	NULL
10B	NULL
)	NULL
.	NULL

Discussion	NULL
Monocytes	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
host	NULL
defense	NULL
,	NULL
largely	NULL
because	NULL
of	NULL
the	NULL
release	NULL
of	NULL
effector	NULL
molecules	NULL
,	NULL
such	NULL
as	NULL
cytokines	NULL
and	NULL
TF	NULL
,	NULL
that	NULL
may	NULL
in	NULL
turn	NULL
mediate	NULL
systemic	NULL
effects	NULL
.	NULL

Tight	NULL
regulation	NULL
of	NULL
this	NULL
process	NULL
is	NULL
indispensable	NULL
for	NULL
the	NULL
prevention	NULL
of	NULL
undue	NULL
tissue	NULL
damage	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
the	NULL
proinflammatory	NULL
activity	NULL
of	NULL
the	NULL
serine	NULL
protease	NULL
plasmin	NULL
extends	NULL
to	NULL
proinflammatory	NULL
gene	NULL
expression	NULL
.	NULL

Plasmin	NULL
triggers	NULL
monocytes	NULL
to	NULL
release	NULL
TNF-	NULL
@	NULL
,	NULL
IL-1	NULL
«	NULL
,	NULL
and	NULL
IL-1B	NULL
and	NULL
to	NULL
express	NULL
TF	NULL
on	NULL
the	NULL
cell	NULL
membrane	NULL
.	NULL

Because	NULL
numerous	NULL
immediate-early	NULL
genes	NULL
,	NULL
including	NULL
cytokines	NULL
and	NULL
TF	NULL
,	NULL
are	NULL
transcrip-tionally	NULL
regulated	NULL
by	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
and	NULL
AP-1	NULL
nuclear	NULL
factors	NULL
,	NULL
``	NULL
>	NULL
63840	NULL
we	NULL
studied	NULL
the	NULL
role	NULL
of	NULL
distinct	NULL
members	NULL
of	NULL
the	NULL
NF-kB	NULL
and	NULL
AP-1	NULL
signaling	NULL
pathways	NULL
in	NULL
the	NULL
plasmin-induced	NULL
monocyte	NULL
activation	NULL
.	NULL

A	NULL
Control	NULL
<	NULL
4-	NULL
IxBa	NULL
KA	NULL
Plasmin	NULL
C	NULL
s	NULL
.	NULL

BML	NULL
<	NULL
+	NULL
icBo	NULL
Control	NULL
amman	NULL
remains	NULL
commas	NULL
:	NULL
«	NULL
alities	NULL
4-	NULL
|Y	NULL
]	NULL
.	NULL

1B	NULL
Plasmin	NULL
-	NULL
tke	NULL
danas	NULL
wam	NULL
WG	NULL
4	NULL
|L	NULL
]	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
0	NULL
10	NULL
30	NULL
60	NULL
120	NULL
B	NULL
M	NULL
E100	NULL
8	NULL
§	NULL
``	NULL
|	NULL
g	NULL
»	NULL
IxBa	NULL
-	NULL
»	NULL
--	NULL
-	NULL
3	NULL
«	NULL
,	NULL
3	NULL
C	NULL
&	NULL
C	NULL
yo	NULL
2	NULL
$	NULL
&	NULL
}	NULL
Q	NULL
‘	NULL
f	NULL
3	NULL
%	NULL
LPS	NULL
Plasmin	NULL
Control	NULL
Figure	NULL
9	NULL
.	NULL

Induction	NULL
of	NULL
IKKB	NULL
activation	NULL
by	NULL
plasmin	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Kinetic	NULL
study	NULL
of	NULL
IKKB	NULL
activation	NULL
.	NULL

Monocytes	NULL
were	NULL
either	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
plasmin	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
.	NULL

for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

IKKB	NULL
was	NULL
precipitated	NULL
from	NULL
the	NULL
cell	NULL
extracts	NULL
with	NULL
a	NULL
specific	NULL
rabbit	NULL
anti-IKKB	NULL
antibody	NULL
and	NULL
protein	NULL
A-agarose	NULL
.	NULL

In	NULL
vitro	NULL
kinase	NULL
assays	NULL
(	NULL
KA	NULL
)	NULL
were	NULL
performed	NULL
using	NULL
IkBa-tagged	NULL
fusion	NULL
protein	NULL
corresponding	NULL
to	NULL
the	NULL
full-length	NULL
human	NULL
IkBa	NULL
(	NULL
amino	NULL
acids	NULL
1-317	NULL
)	NULL
as	NULL
a	NULL
substrate	NULL
.	NULL

Composition	NULL
of	NULL
the	NULL
immunoprecipi-tates	NULL
was	NULL
analyzed	NULL
by	NULL
immunoblot	NULL
with	NULL
mouse	NULL
anti-lKKB	NULL
(	NULL
IB	NULL
)	NULL
.	NULL

Results	NULL
of	NULL
1	NULL
of	NULL
3	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Monocytes	NULL
were	NULL
incubated	NULL
with	NULL
or	NULL
without	NULL
plasmin	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
or	NULL
LPS	NULL
1	NULL
pg/mL	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

IKKB	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
a	NULL
specific	NULL
rabbit	NULL
anti-	NULL
!	NULL

lKKB	NULL
antibody	NULL
.	NULL

Precipitates	NULL
were	NULL
analyzed	NULL
for	NULL
kinase	NULL
activity	NULL
(	NULL
KA	NULL
)	NULL
.	NULL

Phosphorylated	NULL
substrate	NULL
was	NULL
visualized	NULL
by	NULL
autoradiography	NULL
and	NULL
quantified	NULL
densito-metrically	NULL
.	NULL

*P	NULL
<	NULL
.05	NULL
and	NULL
**P	NULL
<	NULL
.01	NULL
versus	NULL
unstimulated	NULL
controls	NULL
.	NULL

Results	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
3	NULL
independent	NULL
experiments	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
JUNE	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
12	NULL
A	NULL
APA+¥	NULL
%	NULL
%	NULL
--	NULL
ap	NULL
Plasmin	NULL
=	NULL
*	NULL
%	NULL
at	NULL
+	NULL
Competitor	NULL
=-	NULL
=-	NULL
AP-1	NULL
SP1	NULL
B	NULL
8	NULL
)	NULL
%	NULL
&	NULL
+	NULL
``	NULL
<	NULL
«	NULL
°	NULL
saggy	NULL
e	NULL
ego	NULL
?	NULL

bpé-bgg	NULL
8	NULL
&	NULL
&	NULL
``	NULL
Supershift	NULL
-	NULL
#	NULL
4	NULL
#	NULL
foﬁ	NULL
‘	NULL
épéf	NULL
c-Fos	NULL
FosB	NULL
$	NULL
hid	NULL
N	NULL
Ap-1-	NULL
»	NULL
t	NULL
ae	NULL
Ch	NULL
,	NULL
Figure	NULL
10	NULL
.	NULL

AP-1	NULL
activation	NULL
in	NULL
plasmin-stimulated	NULL
monocytes	NULL
.	NULL

Binding	NULL
to	NULL
the	NULL
AP-1	NULL
site	NULL
was	NULL
analyzed	NULL
using	NULL
EMSA	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nuclear	NULL
extracts	NULL
(	NULL
10	NULL
mg	NULL
)	NULL
from	NULL
monocytes	NULL
either	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
for	NULL
2	NULL
hours	NULL
with	NULL
plasmin	NULL
0.43	NULL
CTA	NULL
U/mL	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
``	NULL
P-labeled	NULL
DNA	NULL
probe	NULL
containing	NULL
the	NULL
AP-1	NULL
binding	NULL
site	NULL
.	NULL

In	NULL
competition	NULL
experiments	NULL
the	NULL
effects	NULL
of	NULL
specific	NULL
(	NULL
AP-1	NULL
)	NULL
and	NULL
nonspecific	NULL
(	NULL
SP1	NULL
)	NULL
competitors	NULL
at	NULL
100-fold	NULL
molar	NULL
excess	NULL
were	NULL
analyzed	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Composition	NULL
of	NULL
the	NULL
AP-1	NULL
complexes	NULL
was	NULL
characterized	NULL
by	NULL
supershift	NULL
analysis	NULL
with	NULL
antibodies	NULL
against	NULL
Jun	NULL
and	NULL
Fos	NULL
proteins	NULL
.	NULL

Results	NULL
of	NULL
1	NULL
of	NULL
3	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

Endotoxic	NULL
LPS	NULL
,	NULL
one	NULL
of	NULL
the	NULL
most	NULL
potent	NULL
stimuli	NULL
of	NULL
mono-cytes'*	NULL
``	NULL
``	NULL
``	NULL
``	NULL
that	NULL
signals	NULL
through	NULL
was	NULL
used	NULL
for	NULL
comparison	NULL
.	NULL

Apart	NULL
from	NULL
LPS	NULL
,	NULL
signaling	NULL
through	NULL
other	NULL
activators	NULL
,	NULL
such	NULL
as	NULL
TNF-	NULL
«	NULL
,	NULL
IL-1B	NULL
,	NULL
or	NULL
PMA	NULL
,	NULL
also	NULL
converges	NULL
in	NULL
NF-kB	NULL
activation	NULL
in	NULL
monocytes	NULL
and	NULL
monocytic	NULL
cells	NULL
,	NULL
though	NULL
the	NULL
signaling	NULL
cascades	NULL
triggered	NULL
by	NULL
these	NULL
stimuli	NULL
appear	NULL
to	NULL
differ	NULL
markedly.35	NULL
3849	NULL
In	NULL
monocytes	NULL
,	NULL
plasmin	NULL
induces	NULL
rapid	NULL
expression	NULL
of	NULL
TNF-	NULL
,	NULL
IL-1a	NULL
,	NULL
IL-1B	NULL
,	NULL
and	NULL
TF	NULL
mRNA	NULL
,	NULL
followed	NULL
by	NULL
corresponding	NULL
protein	NULL
biosynthesis	NULL
.	NULL

TNF-o	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
supernatant	NULL
of	NULL
plasmin-stimulated	NULL
monocytes	NULL
as	NULL
early	NULL
as	NULL
1	NULL
hour	NULL
after	NULL
stimulation	NULL
.	NULL

Although	NULL
these	NULL
data	NULL
suggested	NULL
a	NULL
direct	NULL
response	NULL
to	NULL
plasmin	NULL
,	NULL
indirect	NULL
monocyte	NULL
stimulation	NULL
through	NULL
autocrine	NULL
loops	NULL
were	NULL
excluded	NULL
in	NULL
additional	NULL
experiments	NULL
.	NULL

Thus	NULL
,	NULL
LTB	NULL
,	NULL
released	NULL
by	NULL
plasmin-stimulated	NULL
PLASMIN	NULL
INDUCTION	NULL
OF	NULL
CYTOKINES	NULL
_	NULL
3947	NULL
monocytes*	NULL
``	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
augmentation	NULL
of	NULL
cytokine	NULL
release	NULL
from	NULL
monocytes	NULL
by	NULL
some	NULL
authors*	NULL
'	NULL
but	NULL
not	NULL
by	NULL
others	NULL
.	NULL
``	NULL

Using	NULL
2	NULL
structurally	NULL
different	NULL
inhibitors	NULL
of	NULL
5-lipoxygenase	NULL
,	NULL
zileu-ton	NULL
,	NULL
and	NULL
MK-886	NULL
,	NULL
at	NULL
concentrations	NULL
that	NULL
totally	NULL
abolished	NULL
plasmin-induced	NULL
formation	NULL
of	NULL
LTB4	NULL
,	NULL
we	NULL
could	NULL
show	NULL
that	NULL
this	NULL
lipid	NULL
mediator	NULL
did	NULL
not	NULL
contribute	NULL
to	NULL
TNF-	NULL
«	NULL
expression	NULL
(	NULL
Syrovets	NULL
et	NULL
al	NULL
,	NULL
unpublished	NULL
results	NULL
,	NULL
July	NULL
1998	NULL
)	NULL
.	NULL

Another	NULL
candidate	NULL
would	NULL
be	NULL
IFN-y	NULL
that	NULL
might	NULL
be	NULL
released	NULL
by	NULL
contaminating	NULL
lymphocytes	NULL
.	NULL

Indeed	NULL
,	NULL
IFN-y	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
exert	NULL
a	NULL
priming	NULL
effect	NULL
on	NULL
LPS-induced	NULL
production	NULL
of	NULL
TNF-	NULL
«	NULL
and	NULL
IL-1B	NULL
by	NULL
human	NULL
monocytes	NULL
.	NULL
``	NULL

However	NULL
,	NULL
for	NULL
enhanced	NULL
cytokine	NULL
production	NULL
,	NULL
at	NULL
least	NULL
the	NULL
costimulation	NULL
of	NULL
LPS	NULL
with	NULL
IFN-y	NULL
is	NULL
required	NULL
``	NULL
``	NULL
;	NULL
optimal	NULL
TNF-a	NULL
expression	NULL
occurred	NULL
only	NULL
after	NULL
pretreatment	NULL
with	NULL
IFN-y	NULL
.	NULL
``	NULL

In	NULL
any	NULL
case	NULL
,	NULL
we	NULL
could	NULL
not	NULL
detect	NULL
any	NULL
IFN-y	NULL
in	NULL
the	NULL
supernatants	NULL
of	NULL
plasmin-stimulated	NULL
monocytes	NULL
,	NULL
excluding	NULL
the	NULL
possibility	NULL
that	NULL
IFN-y	NULL
contributed	NULL
to	NULL
the	NULL
plasmin-induced	NULL
cytokine	NULL
expression	NULL
.	NULL

LPS	NULL
led	NULL
to	NULL
quicker	NULL
and-specifically	NULL
in	NULL
the	NULL
case	NULL
of	NULL
TNF-u-stronger	NULL
mRNA	NULL
expression	NULL
than	NULL
did	NULL
stimulation	NULL
with	NULL
plasmin	NULL
.	NULL

However	NULL
,	NULL
except	NULL
for	NULL
IL-1B	NULL
,	NULL
monocytes	NULL
stimulated	NULL
with	NULL
plasmin	NULL
released	NULL
similar	NULL
or	NULL
even	NULL
higher	NULL
amounts	NULL
of	NULL
cytokines	NULL
and	NULL
generated	NULL
more	NULL
TF	NULL
.	NULL

This	NULL
discrepancy	NULL
could	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
cytokine	NULL
production	NULL
is	NULL
regulated	NULL
on	NULL
multiple	NULL
levels	NULL
,	NULL
such	NULL
as	NULL
mRNA	NULL
stability	NULL
,	NULL
translation	NULL
,	NULL
processing	NULL
and	NULL
secretion	NULL
.	NULL
'	NULL

3	NULL
>	NULL
4548	NULL
Regulation	NULL
of	NULL
mRNA	NULL
stability	NULL
is	NULL
an	NULL
important	NULL
control	NULL
mechanism	NULL
of	NULL
cytokine	NULL
and	NULL
TF	NULL
gene	NULL
expression	NULL
.	NULL
``	NULL

''	NULL
Although	NULL
changes	NULL
in	NULL
the	NULL
half-lives	NULL
might	NULL
differ	NULL
only	NULL
slightly	NULL
,	NULL
they	NULL
can	NULL
affect	NULL
mRNA	NULL
abundance	NULL
by	NULL
orders	NULL
of	NULL
magnitude	NULL
over	NULL
a	NULL
short	NULL
time	NULL
period	NULL
.	NULL

LPS	NULL
up-regulates	NULL
mRNA	NULL
of	NULL
many	NULL
cytokines	NULL
and	NULL
TE	NULL
'	NULL
!	NULL

*	NULL
``	NULL
This	NULL
up-regulation	NULL
is	NULL
partially	NULL
caused	NULL
by	NULL
mRNA	NULL
stabilization	NULL
and	NULL
seems	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
LPS	NULL
induction	NULL
of	NULL
IL-1B.545	NULL
Because	NULL
expression	NULL
of	NULL
cytokine	NULL
and	NULL
TF	NULL
mRNA	NULL
in	NULL
unstimulated	NULL
monocytes	NULL
was	NULL
barely	NULL
detectable	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
stability	NULL
of	NULL
the	NULL
cytokine	NULL
and	NULL
TF	NULL
mRNA	NULL
in	NULL
plasmin	NULL
and	NULL
LPS-stimulated	NULL
cells	NULL
.	NULL

Compared	NULL
with	NULL
LPS	NULL
,	NULL
the	NULL
stability	NULL
of	NULL
all	NULL
plasmin-induced	NULL
mRNAs	NULL
investigated	NULL
was	NULL
decreased	NULL
,	NULL
most	NULL
profoundly	NULL
in	NULL
IL-1B	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
in	NULL
plasmin-treated	NULL
monocytes	NULL
,	NULL
the	NULL
stabilization	NULL
of	NULL
mRNA	NULL
contributed	NULL
less	NULL
to	NULL
gene	NULL
expression	NULL
than	NULL
it	NULL
did	NULL
in	NULL
LPS-stimulated	NULL
cells	NULL
.	NULL

Cytokine	NULL
production	NULL
is	NULL
also	NULL
regulated	NULL
on	NULL
the	NULL
level	NULL
of	NULL
translation	NULL
.	NULL

Stimulation	NULL
of	NULL
monocytic	NULL
cells	NULL
with	NULL
C5a	NULL
,	NULL
hypoxia	NULL
,	NULL
or	NULL
clotting	NULL
blood	NULL
induces	NULL
the	NULL
synthesis	NULL
of	NULL
large	NULL
amounts	NULL
of	NULL
IL-1B	NULL
mRNA	NULL
without	NULL
significant	NULL
translation	NULL
into	NULL
IL-1B	NULL
protein	NULL
.	NULL
``	NULL

''	NULL
This	NULL
dissociation	NULL
between	NULL
transcription	NULL
and	NULL
translation	NULL
is	NULL
characteristic	NULL
of	NULL
IL-1B	NULL
but	NULL
also	NULL
of	NULL
TNF-	NULL
«	NULL
.	NULL

Although	NULL
the	NULL
above	NULL
stimuli	NULL
might	NULL
not	NULL
suffice	NULL
as	NULL
translational	NULL
signals	NULL
despite	NULL
their	NULL
being	NULL
robust	NULL
signals	NULL
for	NULL
transcrip-tion	NULL
,	NULL
LPS	NULL
effectively	NULL
triggers	NULL
both	NULL
processes	NULL
.	NULL
``	NULL

''	NULL
In	NULL
this	NULL
context	NULL
plasmin	NULL
is	NULL
obviously	NULL
a	NULL
less	NULL
potent	NULL
inducer	NULL
of	NULL
IL-1	NULL
than	NULL
LPS	NULL
,	NULL
but	NULL
not	NULL
so	NULL
for	NULL
TNF-	NULL
«	NULL
.	NULL

Further	NULL
,	NULL
the	NULL
degree	NULL
of	NULL
mRNA	NULL
polyadenylation	NULL
might	NULL
influence	NULL
the	NULL
rate	NULL
of	NULL
translation	NULL
.	NULL

Thus	NULL
,	NULL
LPS	NULL
stimulation	NULL
of	NULL
RAW	NULL
264.7	NULL
macrophages	NULL
leads	NULL
to	NULL
a	NULL
200-nucleotide	NULL
increase	NULL
in	NULL
the	NULL
3	NULL
'	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tail	NULL
,	NULL
which	NULL
promotes	NULL
the	NULL
association	NULL
of	NULL
mRNA	NULL
with	NULL
polysomes	NULL
and	NULL
the	NULL
initiation	NULL
of	NULL
translation	NULL
.	NULL
``	NULL

Because	NULL
mRNA	NULL
degradation	NULL
is	NULL
coupled	NULL
to	NULL
ongoing	NULL
translation	NULL
of	NULL
mRNA	NULL
,	NULL
*	NULL
the	NULL
reduced	NULL
stability	NULL
of	NULL
the	NULL
mRNA	NULL
might	NULL
reflect	NULL
the	NULL
increased	NULL
translation	NULL
of	NULL
the	NULL
corresponding	NULL
cytokine	NULL
or	NULL
TF	NULL
in	NULL
plasmin-stimulated	NULL
monocytes	NULL
compared	NULL
with	NULL
LPS-treated	NULL
cells	NULL
.	NULL

Comparing	NULL
the	NULL
amounts	NULL
of	NULL
mRNA	NULL
with	NULL
the	NULL
corresponding	NULL
protein	NULL
expression	NULL
,	NULL
such	NULL
a	NULL
mechanism	NULL
can	NULL
not	NULL
be	NULL
excluded	NULL
for	NULL
IL-1	NULL
«	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
and	NULL
TF	NULL
.	NULL

However	NULL
,	NULL
compared	NULL
with	NULL
LPS-stimulated	NULL
controls	NULL
,	NULL
the	NULL
8-fold	NULL
decreased	NULL
stability	NULL
of	NULL
IL-1B	NULL
mRNA	NULL
in	NULL
plasmin-treated	NULL
cells	NULL
was	NULL
paralleled	NULL
by	NULL
a	NULL
profoundly	NULL
reduced	NULL
protein	NULL
expression	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
accelerated	NULL
mRNA	NULL
decay	NULL
was	NULL
apparently	NULL
not	NULL
caused	NULL
by	NULL
an	NULL
enhanced	NULL
translation	NULL
rate	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3948	NULL
-	NULL
SYROVETS	NULL
etal	NULL
Processing	NULL
and	NULL
secretion	NULL
processes	NULL
may	NULL
be	NULL
particularly	NULL
relevant	NULL
in	NULL
the	NULL
case	NULL
of	NULL
IL-1	NULL
«	NULL
,	NULL
IL-1B	NULL
,	NULL
and	NULL
TNF-	NULL
«	NULL
,	NULL
which	NULL
are	NULL
generated	NULL
in	NULL
pro-forms	NULL
.	NULL

Proteolytic	NULL
processing	NULL
of	NULL
the	NULL
precursors	NULL
of	NULL
IL-1	NULL
«	NULL
and	NULL
IL-1	NULL
f	NULL
by	NULL
calpains	NULL
and	NULL
caspase-1	NULL
,	NULL
respectively	NULL
,	NULL
results	NULL
in	NULL
generation	NULL
of	NULL
the	NULL
mature	NULL
forms	NULL
.	NULL
``	NULL

The	NULL
precursor	NULL
of	NULL
TNF-	NULL
«	NULL
is	NULL
anchored	NULL
to	NULL
the	NULL
cytoplasmic	NULL
membrane	NULL
and	NULL
subsequently	NULL
cleaved	NULL
into	NULL
mature	NULL
,	NULL
soluble	NULL
TNF-	NULL
«	NULL
.	NULL

*°	NULL
This	NULL
processing	NULL
may	NULL
proceed	NULL
through	NULL
matrix	NULL
metalloproteinases	NULL
and	NULL
also	NULL
through	NULL
serine	NULL
proteases	NULL
.	NULL
``	NULL

The	NULL
reported	NULL
ability	NULL
of	NULL
the	NULL
serine	NULL
protease	NULL
plasmin	NULL
to	NULL
promote	NULL
secretion	NULL
of	NULL
biologically	NULL
active	NULL
IL-1*	NULL
``	NULL
might	NULL
also	NULL
contribute	NULL
to	NULL
the	NULL
release	NULL
of	NULL
cytokines	NULL
by	NULL
plasmin-stimulated	NULL
monocytes	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B/Rel	NULL
superfamily	NULL
of	NULL
nuclear	NULL
factors	NULL
provides	NULL
a	NULL
molecular	NULL
basis	NULL
for	NULL
cellular	NULL
responses	NULL
to	NULL
various	NULL
stimuli	NULL
.	NULL

Binding	NULL
sites	NULL
for	NULL
NF-	NULL
were	NULL
found	NULL
in	NULL
promoter	NULL
regions	NULL
of	NULL
different	NULL
proinflammatory	NULL
genes	NULL
,	NULL
including	NULL
IL-1	NULL
«	NULL
,	NULL
IL-1B	NULL
,	NULL
TNF-	NULL
,	NULL
and	NULL
TE	NULL
!	NULL

28484	NULL
Stimulus-specific	NULL
regulation	NULL
of	NULL
proinflammatory	NULL
genes	NULL
is	NULL
assured	NULL
through	NULL
different	NULL
patterns	NULL
of	NULL
NF-kB	NULL
binding	NULL
activity	NULL
.	NULL
``	NULL

LPS	NULL
induction	NULL
of	NULL
TNF-	NULL
«	NULL
in	NULL
monocytic	NULL
cells	NULL
leads	NULL
to	NULL
nuclear	NULL
translocation	NULL
of	NULL
p50/p65	NULL
heterodimers	NULL
.	NULL
'	NULL

''	NULL
Activation	NULL
of	NULL
the	NULL
TF	NULL
gene	NULL
by	NULL
LPS	NULL
,	NULL
however	NULL
,	NULL
requires	NULL
binding	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
to	NULL
the	NULL
B	NULL
sites	NULL
.	NULL
``	NULL

''	NULL
In	NULL
line	NULL
with	NULL
these	NULL
findings	NULL
,	NULL
plasmin	NULL
triggers	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
c-Rel	NULL
proteins	NULL
crucial	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
cytokine	NULL
and	NULL
TF	NULL
genes	NULL
.	NULL

In	NULL
unstimulated	NULL
cells	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
dimers	NULL
are	NULL
kept	NULL
in	NULL
the	NULL
cytoplasm	NULL
through	NULL
interaction	NULL
with	NULL
inhibitory	NULL
IB	NULL
proteins	NULL
.	NULL
``	NULL

IxBB	NULL
degradation	NULL
is	NULL
believed	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
slow	NULL
,	NULL
sustained	NULL
gene	NULL
activation	NULL
,	NULL
whereas	NULL
degradation	NULL
of	NULL
IxBa	NULL
leads	NULL
to	NULL
rapid	NULL
and	NULL
acute	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL
``	NULL

In	NULL
our	NULL
experiments	NULL
,	NULL
plasmin	NULL
led	NULL
to	NULL
rapid	NULL
degradation	NULL
of	NULL
IxBa	NULL
and	NULL
simultaneous	NULL
activation	NULL
of	NULL
NF-kB	NULL
.	NULL

The	NULL
observed	NULL
accumulation	NULL
of	NULL
the	NULL
IxBa	NULL
protein	NULL
2	NULL
hours	NULL
after	NULL
the	NULL
onset	NULL
of	NULL
plasmin	NULL
stimulation	NULL
coincided	NULL
with	NULL
the	NULL
decrease	NULL
of	NULL
the	NULL
NF-KB	NULL
binding	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
induction	NULL
of	NULL
IxBa	NULL
gene	NULL
transcription	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
down-regulation	NULL
of	NULL
the	NULL
NF-KB	NULL
activation	NULL
.	NULL
``	NULL

Factor	NULL
p105	NULL
is	NULL
believed	NULL
to	NULL
have	NULL
dual	NULL
functions	NULL
:	NULL
the	NULL
retention	NULL
of	NULL
proteins	NULL
in	NULL
the	NULL
cytoplasm	NULL
and	NULL
the	NULL
generation	NULL
of	NULL
p50	NULL
through	NULL
processing	NULL
.	NULL

'*	NULL
``	NULL
``	NULL
Coordination	NULL
of	NULL
these	NULL
functions	NULL
during	NULL
cell	NULL
activation	NULL
is	NULL
poorly	NULL
understood	NULL
.	NULL

However	NULL
,	NULL
it	NULL
was	NULL
suggested	NULL
that	NULL
the	NULL
inducible	NULL
proteolysis	NULL
of	NULL
p105	NULL
contributes	NULL
to	NULL
activation	NULL
of	NULL
Transgenic	NULL
mice	NULL
lacking	NULL
p105	NULL
,	NULL
but	NULL
still	NULL
expressing	NULL
p50	NULL
,	NULL
exhibit	NULL
chronic	NULL
inflammation	NULL
,	NULL
stressing	NULL
the	NULL
importance	NULL
of	NULL
p105	NULL
for	NULL
immune	NULL
homeostasis	NULL
.	NULL
``	NULL

IKKs	NULL
physically	NULL
interact	NULL
with	NULL
p105	NULL
and	NULL
inducibly	NULL
phosphorylate	NULL
3	NULL
C-terminal	NULL
serines	NULL
.	NULL

After	NULL
phosphorylation	NULL
,	NULL
p105	NULL
is	NULL
degraded	NULL
.	NULL
'	NULL

>	NULL
``	NULL
*	NULL
We	NULL
demonstrate	NULL
that	NULL
within	NULL
2	NULL
minutes	NULL
,	NULL
plasmin	NULL
initiated	NULL
rapid	NULL
degradation	NULL
of	NULL
p105	NULL
that	NULL
peaked	NULL
at	NULL
10	NULL
minutes	NULL
.	NULL

However	NULL
,	NULL
there	NULL
was	NULL
no	NULL
increase	NULL
in	NULL
p50	NULL
,	NULL
indicating	NULL
complete	NULL
degradation	NULL
instead	NULL
of	NULL
processing	NULL
.	NULL

Interestingly	NULL
,	NULL
similar	NULL
results	NULL
were	NULL
reported	NULL
for	NULL
TNF-o-stimulated	NULL
HeLa	NULL
cells	NULL
in	NULL
which	NULL
TNF-	NULL
@	NULL
stimulation	NULL
reduced	NULL
the	NULL
p105	NULL
half-life	NULL
from	NULL
90	NULL
minutes	NULL
to	NULL
less	NULL
than	NULL
20	NULL
minutes	NULL
.	NULL

``	NULL
©	NULL
Moreover	NULL
,	NULL
p105	NULL
proteolysis	NULL
is	NULL
also	NULL
not	NULL
accompanied	NULL
by	NULL
p50	NULL
accumulation	NULL
.	NULL
``	NULL

''	NULL
In	NULL
our	NULL
experiments	NULL
,	NULL
LPS	NULL
induced	NULL
only	NULL
moderate	NULL
and	NULL
delayed	NULL
proteolysis	NULL
of	NULL
p105	NULL
without	NULL
any	NULL
enhanced	NULL
generation	NULL
of	NULL
p50	NULL
by	NULL
processing	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
p105	NULL
and	NULL
IxBa	NULL
are	NULL
differentially	NULL
sensitive	NULL
targets	NULL
and	NULL
that	NULL
,	NULL
in	NULL
plasmin-stimulated	NULL
monocytes	NULL
,	NULL
proteolysis	NULL
of	NULL
p105	NULL
does	NULL
not	NULL
lead	NULL
to	NULL
the	NULL
processing	NULL
of	NULL
p50	NULL
.	NULL

These	NULL
observations	NULL
are	NULL
supported	NULL
by	NULL
the	NULL
differential	NULL
processing	NULL
of	NULL
IxB	NULL
proteins	NULL
in	NULL
human	NULL
monocytes	NULL
stimulated	NULL
either	NULL
with	NULL
LPS	NULL
or	NULL
TNF-a	NULL
«	NULL
``	NULL
``	NULL
and	NULL
by	NULL
recent	NULL
findings	NULL
demonstrating	NULL
that	NULL
p105	NULL
is	NULL
not	NULL
a	NULL
precursor	NULL
of	NULL
p50.5	NULL
!	NULL

Degradation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
inhibitors	NULL
requires	NULL
their	NULL
phosphorylation	NULL
by	NULL
specific	NULL
kinases	NULL
,	NULL
IKKa	NULL
and	NULL
IKKB	NULL
.	NULL
``	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
BLOOD	NULL
,	NULL
15	NULL
JUNE	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
12	NULL
IKK	NULL
B	NULL
,	NULL
but	NULL
not	NULL
IKKa	NULL
,	NULL
activation	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
kB	NULL
genes	NULL
by	NULL
LPS	NULL
.	NULL
'	NULL

>	NULL
``	NULL
``	NULL
In	NULL
addition	NULL
,	NULL
IKKB	NULL
phosphorylates	NULL
IxBa	NULL
with	NULL
a	NULL
50	NULL
to	NULL
60	NULL
times	NULL
higher	NULL
activity	NULL
than	NULL
IKKa	NULL
.	NULL
``	NULL

However	NULL
,	NULL
IKKa	NULL
is	NULL
rapidly	NULL
activated	NULL
in	NULL
TNF-o-stimulated	NULL
monocytes	NULL
,	NULL
indicating	NULL
that	NULL
it	NULL
might	NULL
contribute	NULL
to	NULL
early	NULL
effects	NULL
during	NULL
TNF-	NULL
@	NULL
signaling	NULL
.	NULL
``	NULL

Preparation	NULL
of	NULL
cell	NULL
extracts	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
%	NULL
Triton	NULL
allowed	NULL
us	NULL
to	NULL
separate	NULL
both	NULL
kinases	NULL
and	NULL
to	NULL
analyze	NULL
them	NULL
differentially	NULL
.	NULL

At	NULL
variance	NULL
with	NULL
TNF-	NULL
«	NULL
,	NULL
``	NULL
``	NULL
there	NULL
was	NULL
no	NULL
detectable	NULL
IKKa	NULL
activation	NULL
after	NULL
plasmin	NULL
stimulation	NULL
.	NULL

As	NULL
with	NULL
LPS	NULL
,	NULL
``	NULL
``	NULL
>	NULL
°	NULL
plasmin	NULL
preferentially	NULL
induced	NULL
activation	NULL
of	NULL
IKK	NULL
in	NULL
monocytes	NULL
.	NULL

In	NULL
light	NULL
of	NULL
the	NULL
critical	NULL
role	NULL
of	NULL
IKKB	NULL
in	NULL
the	NULL
response	NULL
to	NULL
proinflammatory	NULL
stimuli	NULL
,	NULL
``	NULL
this	NULL
finding	NULL
further	NULL
supports	NULL
the	NULL
notion	NULL
that	NULL
plasmin	NULL
acts	NULL
on	NULL
monocytes	NULL
as	NULL
a	NULL
proinflammatory	NULL
activator	NULL
.	NULL

The	NULL
maximum	NULL
activation	NULL
of	NULL
IKK	NULL
occurred	NULL
after	NULL
60	NULL
minutes	NULL
and	NULL
coincided	NULL
with	NULL
the	NULL
degradation	NULL
of	NULL
IxBa	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
NF-KB	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
LPS-stimulated	NULL
cells	NULL
reacted	NULL
more	NULL
rapidly	NULL
,	NULL
and	NULL
maximum	NULL
IKKfB	NULL
activity	NULL
and	NULL
IxBa	NULL
degradation	NULL
was	NULL
already	NULL
observed	NULL
after	NULL
30	NULL
minutes	NULL
.	NULL

Similar	NULL
observations	NULL
were	NULL
made	NULL
in	NULL
LPS-stimulated	NULL
THP-1	NULL
cells	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
plasmin	NULL
and	NULL
LPS	NULL
both	NULL
act	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
IKKB	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IxBa	NULL
«	NULL
and	NULL
p105	NULL
,	NULL
though	NULL
the	NULL
timing	NULL
and	NULL
extent	NULL
of	NULL
these	NULL
processes	NULL
are	NULL
different	NULL
,	NULL
suggesting	NULL
differential	NULL
regulation	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
xB	NULL
sites	NULL
,	NULL
the	NULL
TF	NULL
and	NULL
IL-1f	NULL
promoters	NULL
contain	NULL
2	NULL
AP-1	NULL
sites	NULL
required	NULL
for	NULL
optimal	NULL
gene	NULL
induction	NULL
.	NULL
'	NULL

''	NULL
``	NULL
*	NULL
``	NULL
``	NULL
In	NULL
LPS-stimulated	NULL
THP-1	NULL
cells	NULL
,	NULL
c-Jun-containing	NULL
complexes	NULL
interact	NULL
with	NULL
NE-	NULL
«	NULL
B	NULL
proteins	NULL
and	NULL
synergistically	NULL
enhance	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
.	NULL
``	NULL

''	NULL
Stimulation	NULL
of	NULL
monocytic	NULL
cells	NULL
with	NULL
LPS	NULL
leads	NULL
to	NULL
AP-1	NULL
The	NULL
identity	NULL
of	NULL
the	NULL
proteins	NULL
that	NULL
interact	NULL
with	NULL
the	NULL
AP-1	NULL
site	NULL
in	NULL
the	NULL
resting	NULL
state	NULL
and	NULL
after	NULL
LPS	NULL
stimulation	NULL
remains	NULL
controversial	NULL
.	NULL

Some	NULL
authors	NULL
``	NULL
``	NULL
report	NULL
constitutive	NULL
binding	NULL
of	NULL
JunD	NULL
and	NULL
Fos	NULL
proteins	NULL
,	NULL
which	NULL
is	NULL
supplemented	NULL
by	NULL
c-Jun	NULL
upon	NULL
LPS	NULL
stimulation	NULL
of	NULL
THP-1	NULL
cells	NULL
.	NULL

Others	NULL
``	NULL
find	NULL
constitutive	NULL
binding	NULL
of	NULL
JunD/FRA-2	NULL
heterodimers	NULL
in	NULL
THP-1	NULL
cells	NULL
,	NULL
followed	NULL
by	NULL
phosphorylation	NULL
of	NULL
JunD	NULL
on	NULL
LPS	NULL
exposure	NULL
.	NULL

The	NULL
functional	NULL
consequences	NULL
of	NULL
the	NULL
different	NULL
subunit	NULL
compositions	NULL
of	NULL
AP-1	NULL
are	NULL
poorly	NULL
understood	NULL
,	NULL
though	NULL
it	NULL
is	NULL
acknowledged	NULL
that	NULL
different	NULL
Fos	NULL
and	NULL
Jun	NULL
proteins	NULL
are	NULL
distinct	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
affect	NULL
transcription	NULL
.	NULL
``	NULL

Our	NULL
findings	NULL
suggest	NULL
that	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
THP-1	NULL
cells	NULL
,	NULL
fresh	NULL
monocytes	NULL
cultured	NULL
under	NULL
nonadherent	NULL
conditions	NULL
have	NULL
only	NULL
minimal	NULL
constitutive	NULL
AP-1	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
stimulation	NULL
with	NULL
plasmin	NULL
triggers	NULL
a	NULL
rapid	NULL
increase	NULL
in	NULL
DNA	NULL
binding	NULL
,	NULL
with	NULL
most	NULL
AP-1	NULL
complexes	NULL
composed	NULL
of	NULL
JunD	NULL
,	NULL
c-Fos	NULL
,	NULL
or	NULL
FosB	NULL
dimers	NULL
.	NULL

Despite	NULL
the	NULL
efforts	NULL
from	NULL
many	NULL
laboratories	NULL
,	NULL
the	NULL
molecular	NULL
entity	NULL
of	NULL
the	NULL
putative	NULL
functional	NULL
plasmin	NULL
receptor	NULL
remains	NULL
elusive	NULL
.	NULL

Confirming	NULL
previous	NULL
results	NULL
,	NULL
``	NULL
~	NULL
our	NULL
data	NULL
show	NULL
that	NULL
activation	NULL
requires	NULL
the	NULL
binding	NULL
of	NULL
plasmin	NULL
through	NULL
its	NULL
lysine	NULL
binding	NULL
site	NULL
and	NULL
an	NULL
intact	NULL
catalytic	NULL
center	NULL
,	NULL
implying	NULL
proteolytic	NULL
activation	NULL
.	NULL

Moreover	NULL
,	NULL
similar	NULL
to	NULL
protease-activated	NULL
receptors	NULL
(	NULL
PARs	NULL
)	NULL
,	NULL
plasmin-induced	NULL
signaling	NULL
,	NULL
at	NULL
least	NULL
in	NULL
monocytes	NULL
and	NULL
endothelial	NULL
cells	NULL
,	NULL
apparently	NULL
proceeds	NULL
through	NULL
a	NULL
pertussis	NULL
toxin-sensitive	NULL
G	NULL
protein	NULL
.	NULL

``	NULL
*	NULL
Despite	NULL
suspicious	NULL
similarity	NULL
to	NULL
PARs	NULL
,	NULL
the	NULL
latter	NULL
are	NULL
unlikely	NULL
to	NULL
mediate	NULL
plasmin-induced	NULL
signaling	NULL
.	NULL

Monocytes	NULL
express	NULL
PAR-1	NULL
,	NULL
PAR-2	NULL
,	NULL
and	NULL
PAR-3.545	NULL
``	NULL
However	NULL
,	NULL
neutrophils	NULL
that	NULL
express	NULL
PAR-2	NULL
``	NULL
°	NULL
do	NULL
not	NULL
migrate	NULL
toward	NULL
plas-min	NULL
,	NULL
``	NULL
suggesting	NULL
that	NULL
PAR-2	NULL
is	NULL
not	NULL
involved	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
thrombin	NULL
,	NULL
which	NULL
activates	NULL
PAR-1	NULL
and	NULL
PAR-3	NULL
and	NULL
triggers	NULL
an	NULL
increase	NULL
in	NULL
Ca	NULL
;	NULL
*	NULL
in	NULL
monocytes	NULL
and	NULL
U937	NULL
cells	NULL
,	NULL
``	NULL
``	NULL
``	NULL
``	NULL
plasmin	NULL
does	NULL
not	NULL
do	NULL
so	NULL
(	NULL
Simmet	NULL
et	NULL
al	NULL
,	NULL
unpublished	NULL
data	NULL
,	NULL
February	NULL
1999	NULL
)	NULL
,	NULL
nor	NULL
does	NULL
it	NULL
induce	NULL
any	NULL
increase	NULL
of	NULL
inositol	NULL
1,4,5-trisphosphate	NULL
.	NULL
``	NULL

Moreover	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
plasmin	NULL
,	NULL
thrombin	NULL
is	NULL
hardly	NULL
able	NULL
to	NULL
stimulate	NULL
cytokine	NULL
expression	NULL
in	NULL
monocytes	NULL
.	NULL
``	NULL

Transcleavage	NULL
assays	NULL
revealed	NULL
that	NULL
low	NULL
concentrations	NULL
of	NULL
plasmin	NULL
induce	NULL
the	NULL
BLOOD	NULL
,	NULL
15	NULL
JUNE	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
12	NULL
truncation	NULL
of	NULL
PAR-1	NULL
,	NULL
including	NULL
removal	NULL
of	NULL
the	NULL
SLLR	NULL
epitope	NULL
yielding	NULL
an	NULL
inactivated	NULL
receptor	NULL
.	NULL
``	NULL

Others	NULL
using	NULL
recombinant	NULL
extracellular	NULL
segments	NULL
of	NULL
PARs	NULL
,	NULL
as	NULL
well	NULL
as	NULL
analysis	NULL
by	NULL
MALDI	NULL
mass	NULL
spectrometry	NULL
and	NULL
surface	NULL
plasmon	NULL
resonance	NULL
,	NULL
similarly	NULL
conclude	NULL
that	NULL
plasmin	NULL
would	NULL
disable	NULL
PAR-1	NULL
and	NULL
PAR-2	NULL
.	NULL

Because	NULL
the	NULL
functional	NULL
plasmin	NULL
receptor	NULL
has	NULL
not	NULL
been	NULL
identified	NULL
,	NULL
its	NULL
signaling	NULL
mechanism	NULL
to	NULL
NF-KB	NULL
is	NULL
presently	NULL
unknown	NULL
.	NULL

Plasminogen	NULL
is	NULL
ubiquitously	NULL
distributed	NULL
throughout	NULL
the	NULL
human	NULL
body	NULL
.	NULL

'*	NULL
Generation	NULL
of	NULL
plasmin	NULL
during	NULL
wound	NULL
healing	NULL
,	NULL
``	NULL
thrombus	NULL
organization	NULL
,	NULL
and	NULL
inflammatory	NULL
and	NULL
allergic	NULL
reactions	NULL
``	NULL
``	NULL
sug-	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

References	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

PLASMIN	NULL
INDUCTION	NULL
OF	NULL
CYTOKINES	NULL
3949	NULL
gests	NULL
that	NULL
plasmin-induced	NULL
monocyte	NULL
chemotaxis	NULL
,	NULL
``	NULL
cytokine	NULL
re-lease	NULL
,	NULL
and	NULL
TF	NULL
expression	NULL
might	NULL
contribute	NULL
to	NULL
monocyte	NULL
recruitment	NULL
and	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
these	NULL
processes	NULL
.	NULL

Taking	NULL
into	NULL
account	NULL
previous	NULL
findings	NULL
on	NULL
plasmin-induced	NULL
lipid	NULL
mediator	NULL
release	NULL
,	NULL
``	NULL
``	NULL
we	NULL
propose	NULL
that	NULL
plasmin	NULL
acts	NULL
as	NULL
a	NULL
pathophysiologically	NULL
relevant	NULL
proinflammatory	NULL
stimulus	NULL
for	NULL
human	NULL
monocytes	NULL
.	NULL

Our	NULL
data	NULL
provide	NULL
strong	NULL
evidence	NULL
for	NULL
a	NULL
role	NULL
of	NULL
the	NULL
plasminogen/plasmin	NULL
system	NULL
that	NULL
may	NULL
extend	NULL
far	NULL
beyond	NULL
fibrinolytic	NULL
activities	NULL
.	NULL

Indeed	NULL
plasmin	NULL
may	NULL
participate	NULL
in	NULL
the	NULL
orchestration	NULL
of	NULL
the	NULL
cytokine	NULL
network	NULL
and	NULL
the	NULL
amplification	NULL
of	NULL
inflammatory	NULL
processes	NULL
.	NULL

..	NULL

Plow	NULL
EF	NULL
,	NULL
Herren	NULL
T	NULL
,	NULL
Redlitz	NULL
A	NULL
,	NULL
Miles	NULL
LA	NULL
,	NULL
Hoover	NULL
Plow	NULL
JL	NULL
.	NULL

The	NULL
cell	NULL
biology	NULL
of	NULL
the	NULL
plasminogen	NULL
system	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

1995	NULL
;	NULL
9:939-945	NULL
.	NULL

Weide	NULL
1	NULL
,	NULL
Rémisch	NULL
J	NULL
,	NULL
Simmet	NULL
T.	NULL
Contact	NULL
activation	NULL
triggers	NULL
stimulation	NULL
of	NULL
the	NULL
monocyte	NULL
5-lipoxygenase	NULL
pathway	NULL
via	NULL
plasmin	NULL
.	NULL

Blood	NULL
.	NULL

1994	NULL
;	NULL
83:1941-1951	NULL
.	NULL

Weide	NULL
1	NULL
,	NULL
Tippler	NULL
B	NULL
,	NULL
Syrovets	NULL
T	NULL
,	NULL
Simmet	NULL
T.	NULL
Plasmin	NULL
is	NULL
a	NULL
specific	NULL
stimulus	NULL
of	NULL
the	NULL
5-lipoxygenase	NULL
pathway	NULL
of	NULL
human	NULL
peripheral	NULL
monocytes	NULL
.	NULL

Thromb	NULL
Haemost	NULL
.	NULL

1996	NULL
;	NULL
76:561-568	NULL
.	NULL

Syrovets	NULL
T	NULL
,	NULL
Tippler	NULL
B	NULL
,	NULL
Rieks	NULL
M	NULL
,	NULL
Simmet	NULL
T.	NULL
Plasmin	NULL
is	NULL
a	NULL
potent	NULL
and	NULL
specific	NULL
chemoattractant	NULL
for	NULL
human	NULL
peripheral	NULL
monocytes	NULL
acting	NULL
via	NULL
a	NULL
cyclic	NULL
guanosine	NULL
monophosphate-dependent	NULL
pathway	NULL
.	NULL

Blood	NULL
.	NULL

1997	NULL
;	NULL
89:4574-4583	NULL
.	NULL

Carmeliet	NULL
P	NULL
,	NULL
Collen	NULL
D.	NULL
Development	NULL
and	NULL
disease	NULL
in	NULL
proteinase-deficient	NULL
mice	NULL
:	NULL
role	NULL
of	NULL
the	NULL
plasmino-gen	NULL
,	NULL
matrix	NULL
metalloproteinase	NULL
and	NULL
coagulation	NULL
system	NULL
.	NULL

Thromb	NULL
Res	NULL
.	NULL

1998	NULL
;	NULL
91:255-285	NULL
.	NULL

Ryan	NULL
TJ	NULL
,	NULL
Lai	NULL
L	NULL
,	NULL
Malik	NULL
AB	NULL
.	NULL

Plasmin	NULL
generation	NULL
induces	NULL
neutrophil	NULL
aggregation	NULL
:	NULL
dependence	NULL
on	NULL
the	NULL
catalytic	NULL
and	NULL
lysine	NULL
binding	NULL
sites	NULL
.	NULL

J	NULL
Cell	NULL
Physiol	NULL
.	NULL

1992	NULL
;	NULL
151:255-261	NULL
.	NULL

Shigeta	NULL
O	NULL
,	NULL
Kojima	NULL
H	NULL
,	NULL
Jikuya	NULL
T	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Aprotinin	NULL
inhibits	NULL
plasmin-induced	NULL
platelet	NULL
activation	NULL
during	NULL
cardiopulmonary	NULL
bypass	NULL
.	NULL

Circulation	NULL
.	NULL

1997	NULL
;	NULL
96	NULL
:	NULL
569-574	NULL
.	NULL

Chang	NULL
WC	NULL
,	NULL
Shi	NULL
G-Y	NULL
,	NULL
Chow	NULL
Y-H	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Human	NULL
plasmin	NULL
induces	NULL
a	NULL
receptor-mediated	NULL
arachidonate	NULL
release	NULL
coupled	NULL
with	NULL
G	NULL
proteins	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

Am	NULL
J	NULL
Physiol	NULL
.	NULL

1993	NULL
;	NULL
264:0271-C281	NULL
.	NULL

Carmeliet	NULL
P	NULL
,	NULL
Collen	NULL
D.	NULL
Molecular	NULL
genetics	NULL
of	NULL
the	NULL
fibrinolytic	NULL
and	NULL
coagulation	NULL
systems	NULL
in	NULL
hemosta-sis	NULL
,	NULL
thrombogenesis	NULL
,	NULL
restenosis	NULL
and	NULL
atheroscle-rosis	NULL
.	NULL

Curr	NULL
Opin	NULL
Lipidol	NULL
.	NULL

1997	NULL
;	NULL
8:118-125	NULL
.	NULL

Inman	NULL
RD	NULL
,	NULL
Harpel	NULL
PC	NULL
.	NULL

as-plasmin	NULL
inhibitor-plas-min	NULL
complexes	NULL
in	NULL
synovial	NULL
fluid	NULL
.	NULL

J	NULL
Rheumatol	NULL
.	NULL

1986	NULL
;	NULL
13:535-537	NULL
.	NULL

Schneiderman	NULL
J	NULL
,	NULL
Bordin	NULL
GM	NULL
,	NULL
Engelberg	NULL
I	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Expression	NULL
of	NULL
fibrinolytic	NULL
genes	NULL
in	NULL
atherosclerotic	NULL
abdominal	NULL
aortic	NULL
aneurysm	NULL
wall	NULL
:	NULL
a	NULL
possible	NULL
mechanism	NULL
for	NULL
aneurysm	NULL
expansion	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
.	NULL

1995	NULL
;	NULL
96:639-645	NULL
.	NULL

Karin	NULL
M	NULL
,	NULL
Ben-Neriah	NULL
Y.	NULL
Phosphorylation	NULL
meets	NULL
ubiquination	NULL
:	NULL
the	NULL
control	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
.	NULL

2000	NULL
;	NULL
18:621-663	NULL
.	NULL

Tsuruta	NULL
L	NULL
,	NULL
Arai	NULL
N	NULL
,	NULL
Arai	NULL
K.	NULL
Transcriptional	NULL
control	NULL
of	NULL
cytokine	NULL
genes	NULL
.	NULL

Int	NULL
Rev	NULL
Immunol	NULL
.	NULL

1998	NULL
;	NULL
16:581-616	NULL
.	NULL

Sha	NULL
WC	NULL
.	NULL

Regulation	NULL
of	NULL
immune	NULL
responses	NULL
by	NULL
NF-	NULL
«	NULL
B/Rel	NULL
transcription	NULL
factor	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
.	NULL

1998	NULL
;	NULL
187:143-146	NULL
.	NULL

Bierhaus	NULL
A	NULL
,	NULL
Zhang	NULL
Y	NULL
,	NULL
Deng	NULL
Y	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Mechanism	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
-mediated	NULL
induction	NULL
of	NULL
endothelial	NULL
tissue	NULL
factor	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1995	NULL
;	NULL
270	NULL
:	NULL
26419-26432	NULL
.	NULL

Yao	NULL
J	NULL
,	NULL
Mackman	NULL
N	NULL
,	NULL
Edgington	NULL
TS	NULL
,	NULL
Fan	NULL
ST.	NULL
Lipopolysaccharide	NULL
induction	NULL
of	NULL
the	NULL
turnor	NULL
necrosis	NULL
factor-	NULL
«	NULL
promoter	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
:	NULL
regulation	NULL
by	NULL
Egr-1	NULL
,	NULL
c-Jun	NULL
,	NULL
and	NULL
NF-kB	NULL
transcription	NULL
factors	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1997	NULL
;	NULL
272:17795-17801	NULL
.	NULL

Foletta	NULL
VC	NULL
,	NULL
Segal	NULL
DH	NULL
,	NULL
Cohen	NULL
DR.	NULL
Transcriptional	NULL
20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

286	NULL
.	NULL

29	NULL
.	NULL

30.	NULL
regulation	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
:	NULL
all	NULL
roads	NULL
lead	NULL
to	NULL
AP-1	NULL
.	NULL

J	NULL
Leukoc	NULL
Biol	NULL
.	NULL

1998	NULL
;	NULL
63:139-152.	NULL
.	NULL

Oeth	NULL
P	NULL
,	NULL
Parry	NULL
GC	NULL
,	NULL
Mackman	NULL
N.	NULL
Regulation	NULL
of	NULL
the	NULL
tissue	NULL
factor	NULL
gene	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
:	NULL
role	NULL
of	NULL
AP-1	NULL
,	NULL
NF-	NULL
«	NULL
B/Rel	NULL
,	NULL
and	NULL
Sp1	NULL
proteins	NULL
in	NULL
unin-duced	NULL
and	NULL
lipopolysaccharide-induced	NULL
expression	NULL
.	NULL

Arterioscler	NULL
Thromb	NULL
Vase	NULL
Biol	NULL
.	NULL

1997	NULL
;	NULL
17:365-374.	NULL
.	NULL

Wisdom	NULL
R.	NULL
AP-1	NULL
:	NULL
one	NULL
switch	NULL
for	NULL
many	NULL
signals	NULL
.	NULL

Exp	NULL
Cell	NULL
Res	NULL
.	NULL

1999	NULL
;	NULL
253:180-185	NULL
.	NULL

Cunningham	NULL
MA	NULL
,	NULL
Romas	NULL
P	NULL
,	NULL
Hutchinson	NULL
P	NULL
,	NULL
Hold-sworth	NULL
SR	NULL
,	NULL
Tipping	NULL
PG	NULL
.	NULL

Tissue	NULL
factor	NULL
and	NULL
factor	NULL
Vila	NULL
receptor/ligand	NULL
interactions	NULL
induce	NULL
proinflammatory	NULL
effects	NULL
in	NULL
macrophages	NULL
.	NULL

Blood	NULL
.	NULL

1999	NULL
;	NULL
94:3413-3420	NULL
.	NULL

Takeichi	NULL
O	NULL
,	NULL
Saito	NULL
I	NULL
,	NULL
Tsurumachi	NULL
T	NULL
,	NULL
Saito	NULL
T	NULL
,	NULL
Moro	NULL
I	NULL
.	NULL

Human	NULL
polymorphonuclear	NULL
leukocytes	NULL
derived	NULL
from	NULL
chronically	NULL
inflamed	NULL
tissue	NULL
express	NULL
inflammatory	NULL
cytokines	NULL
in	NULL
vivo	NULL
.	NULL

Cell	NULL
Immunol	NULL
.	NULL

1994	NULL
;	NULL
156	NULL
:	NULL
296-309	NULL
.	NULL

Faucette	NULL
KJ	NULL
,	NULL
Fitzgerald	NULL
LA	NULL
,	NULL
Liu	NULL
L	NULL
,	NULL
Parker	NULL
CJ	NULL
,	NULL
Rodgers	NULL
GM	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
interactions	NULL
between	NULL
procoagulant	NULL
albumin	NULL
and	NULL
human	NULL
endothelial	NULL
cells	NULL
.	NULL

Blood	NULL
.	NULL

1993	NULL
;	NULL
82:2684-2692	NULL
.	NULL

Chiang	NULL
MH	NULL
,	NULL
Steuerwald	NULL
N	NULL
,	NULL
Lambert	NULL
H	NULL
,	NULL
Main	NULL
EK	NULL
,	NULL
Steinleitner	NULL
A	NULL
.	NULL

Detection	NULL
of	NULL
human	NULL
leukocyte	NULL
antigen	NULL
class	NULL
|	NULL
messenger	NULL
ribonucleic	NULL
acid	NULL
transcripts	NULL
in	NULL
hurnan	NULL
spermatozoa	NULL
via	NULL
reverse	NULL
transcription-polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Fertil	NULL
Steril	NULL
.	NULL

1994	NULL
;	NULL
61:276-280	NULL
.	NULL

Adcock	NULL
IM	NULL
,	NULL
Brown	NULL
CR	NULL
,	NULL
Gelder	NULL
CM	NULL
,	NULL
Shirasaki	NULL
H	NULL
,	NULL
Peters	NULL
MJ	NULL
,	NULL
Barnes	NULL
PJ	NULL
.	NULL

Effects	NULL
of	NULL
glucocorticoids	NULL
on	NULL
transcription	NULL
factor	NULL
activation	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
.	NULL

Am	NULL
J	NULL
Physiol	NULL
.	NULL

1995	NULL
;	NULL
268:331-339	NULL
.	NULL

Groupp	NULL
ER	NULL
,	NULL
Donovan-Peluso	NULL
M.	NULL
Lipopolysaccharide	NULL
induction	NULL
of	NULL
THP-1	NULL
cells	NULL
activates	NULL
binding	NULL
of	NULL
c-Jun	NULL
,	NULL
Ets	NULL
,	NULL
and	NULL
Egr-1	NULL
to	NULL
the	NULL
tissue	NULL
factor	NULL
pro-moter	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1996	NULL
;	NULL
271:12423-12430	NULL
.	NULL

Hall	NULL
AJ	NULL
,	NULL
Vos	NULL
HL	NULL
,	NULL
Bertina	NULL
RM	NULL
.	NULL

Lipopolysaccharide	NULL
induction	NULL
of	NULL
TF	NULL
in	NULL
THP-1	NULL
cells	NULL
involves	NULL
Jun	NULL
protein	NULL
phosphorylation	NULL
and	NULL
nuclear	NULL
factor	NULL
kB	NULL
nuclear	NULL
translocation	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1999	NULL
;	NULL
274	NULL
;	NULL
376-383	NULL
.	NULL

Haskill	NULL
S	NULL
,	NULL
Johnson	NULL
C	NULL
,	NULL
Eierman	NULL
D	NULL
,	NULL
Becker	NULL
S	NULL
,	NULL
Warren	NULL
K.	NULL
Adherence	NULL
induces	NULL
selective	NULL
mRNA	NULL
expression	NULL
of	NULL
monocyte	NULL
mediators	NULL
and	NULL
proto-onco-genes	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

1988	NULL
;	NULL
140:1690-1694	NULL
.	NULL

Hmama	NULL
Z	NULL
,	NULL
Knutson	NULL
KL	NULL
,	NULL
Herrera-Velit	NULL
P	NULL
,	NULL
Nandan	NULL
D	NULL
,	NULL
Reiner	NULL
NE	NULL
.	NULL

Monocyte	NULL
adherence	NULL
induced	NULL
by	NULL
lipopolysaccharide	NULL
involves	NULL
CD14	NULL
,	NULL
LFA-1	NULL
,	NULL
and	NULL
cytohesin-1	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1999	NULL
;	NULL
274:1050-1057	NULL
.	NULL

Capodici	NULL
C	NULL
,	NULL
Pillinger	NULL
MH	NULL
,	NULL
Han	NULL
G	NULL
,	NULL
Philips	NULL
MR	NULL
,	NULL
Weissmann	NULL
G.	NULL
Integrin-dependent	NULL
homotypic	NULL
adhesion	NULL
of	NULL
neutrophils	NULL
:	NULL
arachidonic	NULL
acid	NULL
activates	NULL
Raf-1/MEK/ERK	NULL
via	NULL
a	NULL
5-lipoxygenase-dependent	NULL
pathway	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
.	NULL

1998	NULL
;	NULL
102:165-175	NULL
.	NULL

Vermes	NULL
I	NULL
,	NULL
Haanen	NULL
C	NULL
,	NULL
Steffens-Nakken	NULL
H	NULL
,	NULL
Reutel-ingsperger	NULL
C.	NULL
A	NULL
novel	NULL
assay	NULL
for	NULL
apoptosis	NULL
:	NULL
flow	NULL
cytometric	NULL
detection	NULL
of	NULL
phosphatidylserine	NULL
expression	NULL
on	NULL
early	NULL
apoptotic	NULL
cells	NULL
using	NULL
fluorescein	NULL
labeled	NULL
annexin	NULL
V.	NULL
J	NULL
Immunol	NULL
Methods	NULL
.	NULL

1995	NULL
;	NULL
184:39-51	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

Dinarello	NULL
CA	NULL
.	NULL

Interleukin-1	NULL
:	NULL
a	NULL
proinflammatory	NULL
cytokine	NULL
.	NULL

In	NULL
:	NULL
Gallin	NULL
JI	NULL
,	NULL
Snyderman	NULL
R	NULL
,	NULL
eds	NULL
.	NULL

Inflam-mation	NULL
:	NULL
Basic	NULL
Principles	NULL
and	NULL
Clinical	NULL
Correlates	NULL
.	NULL

3rd	NULL
ed	NULL
.	NULL

Philadelphia	NULL
,	NULL
PA	NULL
:	NULL
Lippincott	NULL
Williams	NULL
&	NULL
Wilkins	NULL
;	NULL
1999	NULL
;	NULL
443-461	NULL
.	NULL

Crawford	NULL
EK	NULL
,	NULL
Ensor	NULL
JE	NULL
,	NULL
Kalvakolanu	NULL
I	NULL
,	NULL
Hasday	NULL
JD	NULL
.	NULL

The	NULL
role	NULL
of	NULL
3	NULL
'	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tail	NULL
metabolism	NULL
in	NULL
tumor	NULL
necrosis	NULL
factor-alpha	NULL
regulation	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1997	NULL
;	NULL
272:21120-21127	NULL
.	NULL

@	NULL
sterud	NULL
B.	NULL
Tissue	NULL
factor	NULL
:	NULL
a	NULL
complex	NULL
biological	NULL
role	NULL
.	NULL

Thromb	NULL
Haemost	NULL
.	NULL

1997	NULL
;	NULL
78:755-758	NULL
.	NULL

Neumann	NULL
M	NULL
,	NULL
Fries	NULL
H	NULL
,	NULL
Scheicher	NULL
C	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Differential	NULL
expression	NULL
of	NULL
Re/NF-	NULL
«	NULL
B	NULL
and	NULL
octamer	NULL
factors	NULL
is	NULL
a	NULL
hallmark	NULL
of	NULL
the	NULL
generation	NULL
and	NULL
maturation	NULL
of	NULL
dendritic	NULL
cells	NULL
.	NULL

Blood	NULL
.	NULL

2000	NULL
;	NULL
95:277-285	NULL
.	NULL

Donald	NULL
R	NULL
,	NULL
Ballard	NULL
DW	NULL
,	NULL
Hawiger	NULL
J.	NULL
Proteolytic	NULL
processing	NULL
of	NULL
NF-kB/IkB	NULL
in	NULL
human	NULL
monocytes	NULL
:	NULL
ATP-dependent	NULL
induction	NULL
by	NULL
proinflammatory	NULL
media-tors	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1995	NULL
;	NULL
270:9-12	NULL
.	NULL

Heissmeyer	NULL
V	NULL
,	NULL
Krappmann	NULL
D	NULL
,	NULL
Wulczyn	NULL
FG	NULL
,	NULL
Schei-dereit	NULL
C.	NULL
NF-	NULL
«	NULL
B	NULL
p105	NULL
is	NULL
a	NULL
target	NULL
of	NULL
IxB	NULL
kinases	NULL
and	NULL
controls	NULL
signal	NULL
induction	NULL
of	NULL
Bel-3-p50	NULL
com-plexes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

1999	NULL
;	NULL
18:4766-4778	NULL
.	NULL

Fischer	NULL
C	NULL
,	NULL
Page	NULL
S	NULL
,	NULL
Weber	NULL
M	NULL
,	NULL
Eisele	NULL
T	NULL
,	NULL
Neumeier	NULL
D	NULL
,	NULL
Brand	NULL
K.	NULL
Differential	NULL
effects	NULL
of	NULL
lipopolysaccharide	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
on	NULL
monocytic	NULL
IB	NULL
kinase	NULL
signalsome	NULL
activation	NULL
and	NULL
IkB	NULL
proteolysis	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1999	NULL
;	NULL
274:24625-24632	NULL
.	NULL

O'Connell	NULL
MA	NULL
,	NULL
Bennett	NULL
BL	NULL
,	NULL
Mercurio	NULL
F	NULL
,	NULL
Manning	NULL
AM	NULL
,	NULL
Mackman	NULL
N.	NULL
Role	NULL
of	NULL
IKK1	NULL
and	NULL
IKK2	NULL
in	NULL
lipopolysaccharide	NULL
signaling	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1998	NULL
;	NULL
273:30410-30414	NULL
.	NULL

Hawiger	NULL
J	NULL
,	NULL
Veach	NULL
RA	NULL
,	NULL
Liu	NULL
XY	NULL
,	NULL
Timmons	NULL
S	NULL
,	NULL
Ballard	NULL
DW	NULL
.	NULL

IkB	NULL
kinase	NULL
complex	NULL
is	NULL
an	NULL
intracellular	NULL
target	NULL
for	NULL
endotoxic	NULL
lipopolysaccharide	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
.	NULL

Blood	NULL
.	NULL

1999	NULL
;	NULL
94:1711-1716	NULL
.	NULL

Nasuhara	NULL
Y	NULL
,	NULL
Adcock	NULL
IM	NULL
,	NULL
Catley	NULL
M	NULL
,	NULL
Barnes	NULL
PJ	NULL
,	NULL
Newton	NULL
R.	NULL
Differential	NULL
IkB	NULL
kinase	NULL
activation	NULL
and	NULL
IkBa	NULL
degradation	NULL
by	NULL
interleukin-16	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
in	NULL
human	NULL
U937	NULL
monocytic	NULL
cells	NULL
:	NULL
evidence	NULL
for	NULL
additional	NULL
regulatory	NULL
steps	NULL
in	NULL
B-dependent	NULL
transcription	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1999	NULL
;	NULL
274	NULL
;	NULL
:	NULL
19965-19972	NULL
.	NULL

Rola-Pleszezynski	NULL
M.	NULL
LTB4	NULL
and	NULL
PAF	NULL
in	NULL
the	NULL
cytokine	NULL
network	NULL
.	NULL

Adv	NULL
Exp	NULL
Med	NULL
Biol	NULL
.	NULL

1991	NULL
;	NULL
314:205-221	NULL
.	NULL

Hoffman	NULL
T	NULL
,	NULL
Lee	NULL
YL	NULL
,	NULL
Lizzio	NULL
EF	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Absence	NULL
of	NULL
modulation	NULL
of	NULL
monokine	NULL
production	NULL
via	NULL
endoge-nous	NULL
cyclooxygenase	NULL
or	NULL
5-lipoxygenase	NULL
metabo-lites	NULL
:	NULL
MK-886	NULL
(	NULL
3-	NULL
[	NULL
1-	NULL
(	NULL
4-chlorobenzy	NULL
!	NULL
)	NULL

-3-t-butyl-thio-5-isopropylindol-2-yl|-2,2-dimethylpropanoic	NULL
acid	NULL
)	NULL
,	NULL
indomethacin	NULL
,	NULL
or	NULL
arachidonate	NULL
fail	NULL
to	NULL
alter	NULL
immunoreactive	NULL
interleukin-1	NULL
6	NULL
,	NULL
or	NULL
TNF-	NULL
«	NULL
production	NULL
by	NULL
human	NULL
monocytes	NULL
in	NULL
vitro	NULL
.	NULL

Clin	NULL
Immunol	NULL
Immunopathol	NULL
.	NULL

1991	NULL
;	NULL
58:399-408	NULL
.	NULL

Schindler	NULL
R	NULL
,	NULL
Ghezzi	NULL
P	NULL
,	NULL
Dinarello	NULL
CA	NULL
.	NULL

IL-1	NULL
induces	NULL
IL-1	NULL
,	NULL
IV	NULL
:	NULL
IFN-y	NULL
suppresses	NULL
IL-1	NULL
but	NULL
not	NULL
lipopolysaccharide-induced	NULL
transcription	NULL
of	NULL
IL-1	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

1990	NULL
;	NULL
144:2216-2222	NULL
.	NULL

Hayes	NULL
MP	NULL
,	NULL
Freeman	NULL
SL	NULL
,	NULL
Donnelly	NULL
RP	NULL
.	NULL

IFN-y	NULL
priming	NULL
of	NULL
monocytes	NULL
enhances	NULL
LPS-induced	NULL
TNF	NULL
production	NULL
by	NULL
augmenting	NULL
both	NULL
transcription	NULL
and	NULL
mRNA	NULL
stability	NULL
.	NULL

Cytokine	NULL
.	NULL

1995	NULL
;	NULL
7:427-435	NULL
.	NULL

Ross	NULL
J.	NULL
mRNA	NULL
stability	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mi-crobiol	NULL
Rev	NULL
.	NULL

1995	NULL
;	NULL
59:423-450	NULL
.	NULL

3950	NULL
46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

SYROVETS	NULL
et	NULL
al	NULL
Watanabe	NULL
N	NULL
,	NULL
Nakada	NULL
K	NULL
,	NULL
Kobayashi	NULL
Y	NULL
.	NULL

Processing	NULL
and	NULL
release	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
.	NULL

Eur	NULL
J	NULL
Bio-chem	NULL
.	NULL

1998	NULL
;	NULL
253:576-582	NULL
.	NULL

Matsushima	NULL
K	NULL
,	NULL
Taguchi	NULL
M	NULL
,	NULL
Kovacs	NULL
EJ	NULL
,	NULL
Young	NULL
HA	NULL
,	NULL
Oppenheim	NULL
JJ	NULL
.	NULL

Intracellular	NULL
localization	NULL
of	NULL
human	NULL
monocyte	NULL
associated	NULL
interleukin	NULL
1	NULL
(	NULL
IL	NULL
1	NULL
)	NULL
activity	NULL
and	NULL
release	NULL
of	NULL
biologically	NULL
active	NULL
IL	NULL
1	NULL
from	NULL
monocytes	NULL
by	NULL
trypsin	NULL
and	NULL
plasmin	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

1986	NULL
;	NULL
136:2883-2891	NULL
.	NULL

Goto	NULL
M	NULL
,	NULL
Katayama	NULL
KI	NULL
,	NULL
Shirakawa	NULL
F	NULL
,	NULL
Tanaka	NULL
1	NULL
.	NULL

Involvement	NULL
of	NULL
NF-xB	NULL
p50/p65	NULL
heterodimer	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
hurnan	NULL
prointerleukin-1B	NULL
gene	NULL
at	NULL
two	NULL
subregions	NULL
of	NULL
the	NULL
upstream	NULL
enhancer	NULL
ele-ment	NULL
.	NULL

Cytokine	NULL
.	NULL

1999	NULL
;	NULL
11:16-28	NULL
.	NULL

Udalova	NULL
IA	NULL
,	NULL
Knight	NULL
JC	NULL
,	NULL
Vidal	NULL
V	NULL
,	NULL
Nedospasov	NULL
SA	NULL
,	NULL
Kwiatkowski	NULL
D.	NULL
Complex	NULL
NF-	NULL
«	NULL
B	NULL
interactions	NULL
at	NULL
the	NULL
distal	NULL
turnor	NULL
necrosis	NULL
factor	NULL
promoter	NULL
region	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1998	NULL
;	NULL
273	NULL
:	NULL
21178-21186	NULL
.	NULL

Harhaj	NULL
EW	NULL
,	NULL
Maggirwar	NULL
SB	NULL
,	NULL
Sun	NULL
SC	NULL
.	NULL

Inhibition	NULL
of	NULL
p105	NULL
processing	NULL
by	NULL
NF-kB	NULL
proteins	NULL
in	NULL
transiently	NULL
transfected	NULL
cells	NULL
.	NULL

Oncogene	NULL
.	NULL

1996	NULL
;	NULL
12:2385-2392	NULL
.	NULL

Lin	NULL
L	NULL
,	NULL
DeMartino	NULL
GN	NULL
,	NULL
Greene	NULL
WC	NULL
.	NULL

Cotransla-tional	NULL
biogenesis	NULL
of	NULL
NF-xB	NULL
p50	NULL
by	NULL
the	NULL
26S	NULL
pro-teasome	NULL
.	NULL

Cell	NULL
.	NULL

1998	NULL
;	NULL
92:819-828	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

Li	NULL
J	NULL
,	NULL
Peet	NULL
GW	NULL
,	NULL
Pullen	NULL
SS	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Recombinant	NULL
IB	NULL
kinases	NULL
«	NULL
and	NULL
B	NULL
are	NULL
direct	NULL
kinases	NULL
of	NULL
IkBe	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1998	NULL
;	NULL
273:30736-30741	NULL
.	NULL

Stylianou	NULL
E	NULL
,	NULL
Saklatvala	NULL
J	NULL
.	NULL

Interleukin-1	NULL
.	NULL

Int	NULL
J	NULL
Bio-chem	NULL
Cell	NULL
Biol	NULL
.	NULL

1998	NULL
;	NULL
30:1075-1079	NULL
.	NULL

Jendrach	NULL
M	NULL
,	NULL
Colognato	NULL
R	NULL
,	NULL
Syrovets	NULL
T	NULL
,	NULL
Simmet	NULL
T.	NULL
Characterization	NULL
of	NULL
protease-activated	NULL
receptors	NULL
in	NULL
human	NULL
peripheral	NULL
monocytes	NULL
[	NULL
abstract	NULL
]	NULL
.	NULL

Naunyn	NULL
Schmiedebergs	NULL
Arch	NULL
Pharmacol	NULL
.	NULL

2000	NULL
;	NULL
362	NULL
(	NULL
suppl	NULL
)	NULL
:34	NULL
.	NULL

Colognato	NULL
R	NULL
,	NULL
Slupsky	NULL
JR	NULL
,	NULL
Jendrach	NULL
M	NULL
,	NULL
Syrovets	NULL
T	NULL
,	NULL
Simmet	NULL
T.	NULL
Interleukin-4	NULL
regulates	NULL
protease-activated	NULL
receptor	NULL
expression	NULL
on	NULL
human	NULL
peripheral	NULL
monocytes	NULL
[	NULL
abstract	NULL
]	NULL
.	NULL

Naunyn	NULL
Schmiedebergs	NULL
Arch	NULL
Pharmacol	NULL
.	NULL

2000	NULL
;	NULL
362	NULL
(	NULL
supp	NULL
!	NULL
)	NULL

:8	NULL
.	NULL

Howells	NULL
GL	NULL
,	NULL
Macey	NULL
MG	NULL
,	NULL
Chinni	NULL
C	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Protein-ase-activated	NULL
receptor-2	NULL
:	NULL
expression	NULL
by	NULL
human	NULL
neutrophils	NULL
.	NULL

J	NULL
Cell	NULL
Sci	NULL
.	NULL

1997	NULL
;	NULL
110:881-887	NULL
.	NULL

Hoffman	NULL
M	NULL
,	NULL
Church	NULL
FC	NULL
.	NULL

Response	NULL
of	NULL
blood	NULL
leukocytes	NULL
to	NULL
thrombin	NULL
receptor	NULL
peptides	NULL
.	NULL

J	NULL
Leukoc	NULL
Biol	NULL
.	NULL

1993	NULL
;	NULL
54:145-151	NULL
.	NULL

Joseph	NULL
S	NULL
,	NULL
MacDermot	NULL
J	NULL
.	NULL

The	NULL
N-terminal	NULL
thrombin	NULL
receptor	NULL
fragment	NULL
SFLLRN	NULL
,	NULL
but	NULL
not	NULL
catalytically	NULL
inactive	NULL
thrombin-derived	NULL
agonists	NULL
,	NULL
activate	NULL
U937	NULL
59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
JUNE	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
12	NULL
human	NULL
monocytic	NULL
cells	NULL
:	NULL
evidence	NULL
for	NULL
receptor	NULL
hydrolysis	NULL
in	NULL
thrombin-dependent	NULL
signalling	NULL
.	NULL

Bio-chem	NULL
J	NULL
.	NULL

1993	NULL
;	NULL
290:571-577	NULL
.	NULL

Kranzhéfer	NULL
R	NULL
,	NULL
Clinton	NULL
SK	NULL
,	NULL
Ishii	NULL
K	NULL
,	NULL
Coughlin	NULL
SR	NULL
,	NULL
Fenton	NULL
JW	NULL
II	NULL
,	NULL
Libby	NULL
P.	NULL
Thrombin	NULL
potently	NULL
stimulates	NULL
cytokine	NULL
production	NULL
in	NULL
human	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
mononuclear	NULL
phagocytes	NULL
.	NULL

Circ	NULL
Res	NULL
.	NULL

1996	NULL
;	NULL
79:286-294	NULL
.	NULL

Kuliopulos	NULL
A	NULL
,	NULL
Covic	NULL
L	NULL
,	NULL
Seeley	NULL
SK	NULL
,	NULL
Sheridan	NULL
PJ	NULL
,	NULL
Helin	NULL
J	NULL
,	NULL
Costello	NULL
CE	NULL
.	NULL

Plasmin	NULL
desensitization	NULL
of	NULL
the	NULL
PAR1	NULL
thrombin	NULL
receptor	NULL
:	NULL
kinetics	NULL
,	NULL
sites	NULL
of	NULL
truncation	NULL
,	NULL
and	NULL
implications	NULL
for	NULL
thrombolytic	NULL
therapy	NULL
.	NULL

Biochemistry	NULL
.	NULL

1999	NULL
;	NULL
38:4572-4582	NULL
.	NULL

Loew	NULL
D	NULL
,	NULL
Perrault	NULL
C	NULL
,	NULL
Morales	NULL
M	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Proteolysis	NULL
of	NULL
the	NULL
exodomain	NULL
of	NULL
recombinant	NULL
protease-activated	NULL
receptors	NULL
:	NULL
prediction	NULL
of	NULL
receptor	NULL
activation	NULL
or	NULL
inactivation	NULL
by	NULL
MALDI	NULL
mass	NULL
spectrometry	NULL
.	NULL

Biochemistry	NULL
.	NULL

2000	NULL
;	NULL
39:10812-10822	NULL
.	NULL

Remer	NULL
J	NULL
,	NULL
Brugge	NULL
TH	NULL
,	NULL
Pyke	NULL
C	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Impaired	NULL
wound	NULL
healing	NULL
in	NULL
mice	NULL
with	NULL
a	NULL
disrupted	NULL
plasminogen	NULL
gene	NULL
.	NULL

Nat	NULL
Med	NULL
.	NULL

1996	NULL
;	NULL
2:287-292	NULL
.	NULL

Kaplan	NULL
AP	NULL
,	NULL
Silverberg	NULL
M.	NULL
The	NULL
coagulation-kinin	NULL
pathway	NULL
of	NULL
human	NULL
plasma	NULL
.	NULL

Blood	NULL
.	NULL

1987	NULL
;	NULL
70:1-15	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
2001	NULL
97	NULL
:	NULL
3941-3950	NULL
doi:10.1182/blood.V97.12.3941	NULL
Plasmin-induced	NULL
expression	NULL
of	NULL
cytokines	NULL
and	NULL
tissue	NULL
factor	NULL
in	NULL
human	NULL
monocytes	NULL
involves	NULL
AP-1	NULL
and	NULL
IKK	NULL
B-mediated	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
Tatiana	NULL
Syrovets	NULL
,	NULL
Marina	NULL
Jendrach	NULL
,	NULL
Angela	NULL
Rohwedder	NULL
,	NULL
Almut	NULL
Schule	NULL
and	NULL
Thomas	NULL
Simmet	NULL
A	NULL
TY	NULL
O	NULL
0C	NULL
,	NULL
f	NULL
gm	NULL
“	NULL
CA	NULL
N	NULL
,	NULL
6	NULL
'	NULL
%	NULL
:	NULL
r	NULL
)	NULL
...	NULL
3\	NULL
2	NULL
``	NULL
O10	NULL
(	NULL
@	NULL
0	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/97/12/3941.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Gene	NULL
Expression	NULL
(	NULL
1086	NULL
articles	NULL
)	NULL
Phagocytes	NULL
(	NULL
969	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

